Benzothiazinones Kill Mycobacterium tuberculosis by blocking Arabinan synthesis
Makarov, Vadim Manina, Giulia Mikusova, Katarina Moellmann, Ute Ryabova, Olga Saint-Joanis, Brigitte Dhar, Neeraj Pasca, Maria Rosalia Buroni, Silvia Lucarelli, Anna Paola Milano, Anna De Rossi, Edda Belanova, Martina Bobovska, Adela Dianiskova, Petronela Kordulakova, Jana Sala, Claudia Fullam, Elizabeth Schneider, Patricia McKinney, John D. Brodin, Priscille Christophe, Thierry Waddell, Simon Butcher, Philip Albrethsen, Jakob Rosenkrands, Ida Brosch, Roland Nandi, Vrinda Bharath, Sowmya Gaonkar, Sheshagiri Shandil, Radha K. Balasubramanian, Venkataraman Balganesh, Tanjore Tyagi, Sandeep Grosset, Jacques Riccardi, Giovanna Cole, Stewart T.
Giovanna RICCARDI
RICCARDI Giovanna
ORCID: 0000-0003-3295-0070
Mycobacterium tuberculosis: Drug resistance and future perspectives 10.2217/fmb.09.20
Sequence of the Bacillus stearothermophilus gene encoding aspartokinase II 10.1016/0378-1119(95)00834-9
Antituberculars which target decaprenylphosphoryl-β-Dribofuranose 2′-oxidase DprE1: State of art 10.1007/s00253-012-4013-4
Gene arrangement and organization in a ~ 76 kb fragment: Encompassing the oriC region of the chromosome of Mycobacterium leprae 10.1099/13500872-142-11-3147
Organization of the origins of replication of the chromosomes of Mycobacterium smegmatis, Mycobacterium leprae and Mycobacterium tuberculosis and isolation of a functional origin from M. smegmatis 10.1111/j.1365-2958.1996.tb02617.x
Detection and characterization of naturally occurring plasmids in Bacillus licheniformis 10.1111/j.1574-6968.1991.tb04781.x
Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms 10.1128/AAC.01571-10
Differential roles of rnd efflux pumps in antimicrobial drug resistance of sessile and planktonic burkholderia cenocepacia cells 10.1128/AAC.03800-14
Erratum: Antituberculars which target decaprenylphosphoryl-β-D- ribofuranose 2'-oxidase DprE1: State of art (Applied Microbiology and Biotechnology (2012) 94 (907-916) DOI: 10.1007/s00253-012-4013-4) 10.1007/s00253-012-4217-7
Antibiotic resistance of benthic bacteria in fish-farm and control sediments of the Western Mediterranean 10.1016/S0044-8486(03)00016-4
Amino acid biosynthesis and its regulation in cyanobacteria 10.1016/0168-9452(89)90018-6
Characterization of Gram-positive broad host-range plasmids carrying a thermophilic replicon 10.1016/0923-2508(91)90108-M
4-Aminoquinolone piperidine amides: Noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity 10.1021/jm5005978
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates 10.1089/mdr.2011.0019
Benzothiazinones Kill Mycobacterium tuberculosis by blocking Arabinan synthesis 10.1126/science.1171583
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance 10.1186/1471-2180-9-200
Erratum: Global analysis of the Mycobacterium tuberculosis zur (FurB) regulon (Journal of Bacteriology (2007) 189, 3, (730-740)) 10.1128/JB.00593-07
Molecular characterization of the genes encoding acetohydroxy acid synthase in the cyanobacterium Spirulina platensis 10.1099/00221287-138-7-1399
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 10.1186/1471-2180-6-66
Role of mycobacterial efflux transporters in drug resistance: An unresolved question 10.1111/j.1574-6976.2005.00002.x
Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems 10.1371/journal.pone.0055112
Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium 10.1007/s00253-011-3616-5
Heterologous expression, purification, and enzymatic activity of Mycobacterium tuberculosis NAD+ synthetase 10.1016/S1046-5928(02)00041-4
Transcriptional analysis of ESAT-6 cluster 3 in Mycobacterium smegmatis 10.1186/1471-2180-9-48
Genomic analysis of zinc homeostasis in Mycobacterium tuberculosis 10.1111/j.1574-6968.2008.01320.x
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia 10.1128/AAC.02438-13
Determination of a 15437 bp nucleotide sequence around the inhA gene of Mycobacterium avium and similarity analysis of the products of putative ORFs 10.1099/00221287-144-3-807
Biochemical evidence for multiple forms of acetohydroxy acid synthase in Spirulina platensis 10.1007/BF00252216
Investigating the mechanism of action of diketopiperazines inhibitors of the burkholderia cenocepacia quorum sensing synthase CepI: A site-directed mutagenesis study 10.3389/fphar.2018.00836
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis 10.1126/scitranslmed.3004395
Biochemical characterization of glutamate Racemase - A new candidate drug target against Burkholderia cenocepacia infections 10.1371/journal.pone.0167350
Cloning and sequencing of the ilvBNC gene cluster from Mycobacterium avium 10.1016/0378-1119(96)00275-2
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis 10.1021/cb500149m
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system 10.1016/j.tube.2008.08.003
Molecular cloning and expression of Spirulina platensis acetohydroxy acid synthase genes in Escherichia coli 10.1007/BF00243456
Development of a repressible mycobacterial promoter system based on two transcriptional repressors 10.1093/nar/gkq235
Characterisation and antimicrobial activity of epibiotic bacteria from Petrosia ficiformis (Porifera, Demospongiae) 10.1016/j.jembe.2004.03.006
Genetic transformation of intact cells of Bacillus subtilis by electroporation 10.1016/0378-1097(90)90182-P
Transcriptional regulation of furA and katG upon oxidative stress in Mycobacterium smegmatis 10.1128/JB.183.23.6801-6806.2001
Mechanism of action of 5-nitrothiophenes against mycobacterium tuberculosis 10.1128/AAC.02693-13
The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis 10.1007/s00253-013-5218-x
Burkholderia cenocepacia infections in cystic fibrosis patients: Drug resistance and therapeutic approaches 10.3389/fmicb.2017.01592
Structural organization of pBC1, a cryptic plasmid from Bacillus coagulans 10.1128/jb.174.2.638-642.1992
Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia 10.1016/j.tim.2019.12.005
Raising awareness of the importance of funding for tuberculosis small-molecule research 10.1016/j.drudis.2016.09.012
Bacterial community structure and activity in fish farm sediments of the Ligurian Sea (Western Mediterranean) 10.1023/A:1021365829687
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance 10.1111/j.1365-2958.2010.07277.x
The Crystal Structure of Burkholderia cenocepacia DfsA Provides Insights into Substrate Recognition and Quorum Sensing Fatty Acid Biosynthesis 10.1021/acs.biochem.6b00178
The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens 10.1016/j.ejmech.2020.112132
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors 10.1021/acsinfecdis.7b00006
Deciphering the role of rnd efflux transporters in burkholderia cenocepacia 10.1371/journal.pone.0018902
Exploring the HME and HAE1 efflux systems in the genus Burkholderia 10.1186/1471-2148-10-164
Plasmid screening in thermophilic Bacillus: Physical characterization and molecular cloning 10.1007/BF01568897
The Mycobacterium tuberculosis Rv2358-furB operon is induced by zinc 10.1016/j.resmic.2003.11.009
New prodrugs against tuberculosis 10.1016/j.drudis.2016.09.006
Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target 10.2174/092986710791959693
Molecular cloning and sequencing of the β-isopropylmalate dehydrogenase gene from the cyanobacterium Spirulina platensis 10.1099/00221287-138-3-493
Cloning of the glutamine synthetase gene from spirulina platensis 10.1007/BF02418760
Characterization of a mutant of chlamydomonas reinhardtII resistant to fusidic acid 10.1016/0014-5793(81)81166-0
Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo 10.1038/srep32487
A highly efficient electroporation system for transformation of Bacillus licheniformis 10.1007/BF00152745
Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ 10.1128/AAC.01231-18
A census of RND superfamily proteins in the Burkholderia genus 10.2217/fmb.13.50
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 10.1128/AAC.00656-06
Global analysis of the Mycobacterium tuberculosis Zur (FurB) regulon 10.1128/JB.01190-06
Mycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: Biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesis 10.1371/journal.pone.0015494
New tuberculosis drugs on the horizon 10.1016/j.mib.2011.07.022
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 10.1038/s41598-018-21614-4
Rv2358 and FurB: Two transcriptional regulators from Mycobacterium tuberculosis which respond to zinc 10.1128/JB.187.16.5837-5840.2005
Mycobacterium tuberculosis H37Rv comparative gene-expression analysis in synthetic medium and human macrophage 10.1016/S0378-1119(00)00249-3
In vitro translation of chloroplast mRNAs 10.1016/0304-4211(82)90148-1
High content screening identifies decaprenyl-phosphoribose 2′ epimerase as a target for intracellular antimycobacterial inhibitors 10.1371/journal.ppat.1000645
The redox state regulates the conformation of Rv2466c to activate the antitubercular prodrug TP053 10.1074/jbc.M115.677039
Biofilm-Grown Burkholderia cepacia Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species 10.1371/journal.pone.0058943
Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesin from Streptococcus dysgalactiae 10.1016/S1570-9639(03)00020-7
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675
Erratum: Rv2358 and FurB: Two transcriptional regulators from Mycobacterium tuberculosis which respond to zinc (Journal of Bacteriology (2005) 187, 16 (5837-5840)) 10.1128/JB.00141-07
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain 10.1016/j.resmic.2004.08.011
Techniques and Applications: The heterologous expression of Mycobacterium tuberculosis genes is an uphill road 10.1016/S0966-842X(03)00180-X
Characterization of mutants of Spirulina platensis resistant to amino acid analogues 10.1111/j.1574-6968.1981.tb07668.x
The TB structural genomics consortium: A resource for Mycobacterium tuberculosis biology 10.1016/S1472-9792(03)00051-9
Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones 10.1128/AAC.01676-09
New shuttle vector for cloning in Bacillus stearothermophilus 10.1016/0923-2508(94)90074-4
Biochemical characterization and cloning of acetohydroxy acid synthase from spirulina platensis 10.1080/11263509009430656
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator 10.1128/JB.00631-09
Trends in discovery of new drugs for tuberculosis therapy 10.1038/ja.2014.109
DprE1, a new taxonomic marker in mycobacteria 10.1111/1574-6968.12246
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia 10.3389/fmicb.2015.00815
mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis 10.1128/AAC.49.11.4775-4777.2005
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis 10.1128/AAC.48.8.3175-3178.2004
Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance 10.1016/S0378-1097(00)00456-0
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG 10.1016/j.chembiol.2015.05.016
Mycobacterium tuberculosis fura autoregulates its own expression 10.1128/JB.185.18.5357-5362.2003
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection 10.1016/j.nano.2019.102113
Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-d-ribofuranose 2′-oxidase DprE1 10.1021/ja211042r
New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053 10.1021/acsinfecdis.9b00388
2-carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1 10.1021/cb5007163
The katE gene, which encodes the catalase HPII of Mycobacterium avium 10.1046/j.1365-2958.1996.352876.x
Sequence of the gene encoding an alkaline serine protease of thermophilic Bacillus smithii 10.1016/0378-1119(94)90340-9
Cloning, sequencing and expression of the ilvBNC gene cluster from Streptomyces avermitilis 10.1016/0378-1119(95)00563-4
Philip Butcher
Butcher Philip
ORCID: 0000-0003-1223-9097
Intracellular Microbe Whole-Genome Expression Profiling: Methodological Considerations and Biological Inferences 10.1002/9783527629176.ch9
Investigation of mycobacteria in Crohn's disease tissue by Southern blotting and DNA hybridisation with cloned mycobacterial genomic DNA probes from a Crohn's disease isolated mycobacteria 10.1136/gut.29.9.1222
Fidelity and reproducibility of antisense RNA amplification for the study of gene expression in human CD34 + haemopoietic stem and progenitor cells 10.1046/j.1365-2141.2003.04440.x
Analysis of whole-genome microarray replicates using mixed models 10.1093/bioinformatics/19.1.53
Evidence for a role for interleukin-17, Th17 cells and iron homeostasis in protective immunity against tuberculosis in cynomolgus macaques 10.1371/journal.pone.0088149
Inactivation of polyketide synthase and related genes results in the loss of complex lipids in Mycobacterium tuberculosis H37Rv 10.1111/j.1472-765X.2005.01659.x
Use of Genome Level-Informed PCR as a New Investigational Approach for Analysis of Outbreak-Associated Mycobacterium tuberculosis Isolates 10.1128/JCM.42.5.1890-1896.2004
Characterization of a haemolysin from Mycobacterium tuberculosis with homology to a virulence factor of Serpulina hyodysenteriae 10.1099/00221287-144-5-1205
Mycobacterium tuberculosis expresses a novel pH-dependent divalent cation transporter belonging to the Nramp family 10.1084/jem.190.5.717
Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission 10.1136/mp.56.2.121
Application of the polymerase chain reaction to the diagnosis of human toxoplasmosis 10.1016/0163-4453(93)92788-X
Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria 10.1371/journal.pone.0184510
DNA microarrays for virus detection in cases of central nervous system infection 10.1128/JCM.42.12.5811-5818.2004
Antibodies to gut protozoa in commercial immunoglobulin preparations 10.1016/0035-9203(91)90163-S
cDNA-RNA subtractive hybridization reveals increased expression of mycocerosic acid synthase in intracellular Mycobacterium bovis BCG 10.1099/00221287-147-8-2293
Benzothiazinones Kill Mycobacterium tuberculosis by blocking Arabinan synthesis 10.1126/science.1171583
Methionine sulfoximine resistance in mycobacterium tuberculosis is due to a single nucleotide deletion resulting in increased expression of the major glutamine synthetase, GlnA1 10.1089/mdr.2010.0125
Whole genome analysis using microarrays 10.1007/978-1-59745-207-6_6
Genome sequencing and characterization of an extensively drug-resistant sequence type 111 serotype O12 hospital outbreak strain of Pseudomonas aeruginosa 10.1111/1469-0691.12528
Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide 10.1128/JB.182.22.6358-6365.2000
A polymerase chain reaction to detect a spliced late transcript of human cytomegalovirus in the blood of bone marrow transplant recipients 10.1016/0166-0934(95)01900-6
Differential expression of mycobacterial proteins following phagocytosis by macrophages 10.1099/00221287-147-2-459
Mycobacterial P 1-Type ATPases mediate resistance to Zinc poisoning in human macrophages 10.1016/j.chom.2011.08.006
Advanced significance analysis of microarray data based on weighted resampling: A comparative study and application to gene deletions in Mycobacterium bovis 10.1093/bioinformatics/btg417
BμG@Sbase - A microbial gene expression and comparative genomic database 10.1093/nar/gkr796
Genetic Composition of Mycobacterium bovis BCG Substrain Sofia [2] 10.1128/JCM.41.11.5349.2003
A comparative study of haemoglobins from the artiodactyla by isoelectric focusing 10.1016/0305-0491(77)90025-6
XDR-TB transmission in London: Case management and contact tracing investigation assisted by early whole genome sequencing 10.1016/j.jinf.2016.04.037
Haemoglobins and erythrocyte sickling in the artiodactyla: A survey 10.1016/0300-9629(77)90134-7
Cytokine mRNA expression in Mycobacteriam ulcerans-infected human skin and correlation with local inflammatory response 10.1128/IAI.74.5.2917-2924.2006
Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases 10.1128/JCM.02993-14
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis 10.1056/NEJMoa1314210
Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum 10.1371/journal.pmed.0050075
Performance evaluation of automated urine microscopy as a rapid, non-invasive approach for the diagnosis of non-gonococcal urethritis 10.1136/sextrans-2014-051761
The nature of erythrocyte sickling in sheep 10.1016/0300-9629(79)90462-6
Serodiagnosis of giardiasis 10.1016/0888-0786(87)90001-1
Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages 10.1371/journal.pone.0001403
Comparative studies on the glycoprotein composition of mammalian platelets 10.1016/0305-0491(77)90240-1
Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics 10.1128/AEM.71.11.7504-7514.2005
Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008–2014 10.1016/j.jinf.2016.12.005
Comparison of human low-molecular-weight RNA from normal and Crohn's disease derived blood and mesenteric, lymph node leucocytes 10.1042/bst0121112
Microarrays for microbes: The BμGΣ approach 10.1002/cfg.187
Gene expression during host—pathogen interactions: Approaches to bacterial mRNA extraction and labelling for microarray analysis 10.1016/S0580-9517(02)33009-5
Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity 10.1101/gr.185801
Microarray-based comparative genomics: Genome plasticity in Mycobacterium bovis 10.1002/cfg.182
The heat shock response of Mycobacterium tuberculosis: Linking gene expression, immunology and pathogenesis 10.1002/cfg.183
Prevalence of giardia in dogs and cats in the United Kingdom: Survey of an essex veterinary clinic 10.1016/0035-9203(89)90330-1
Potassium availability triggers Mycobacterium tuberculosis transition to, and resuscitation from, non-culturable (dormant) states 10.1098/rsob.140106
The 1st Symposium of the Wellcome Trust-funded Multi-collaborative Microbial Pathogen Microarray Facility - BμGΣ 2002: 'Bacterial pathogens, microarrays and functional genomics' 10.1002/cfg.189
Human cytomegalovirus genome sequences in lymph nodes 10.1016/S1286-4579(99)80023-9
Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial 10.1186/s12916-017-0834-4
The electrophoretic analysis of low molecular weight nucleic acids from Crohn's disease tissues in the search for an unconventional small infections agent 10.1007/BF01310895
Modulation of pristane-induced arthritis by mycobacterial antigens 10.3109/08916939108994706
Association of cytomegalovirus infection with post‐transplantation cardiac rejection as studied using the polymerase chain reaction 10.1002/jmv.1890420412
Gene markers in 40 Przewalski horses: Equus przewahkii 10.1111/j.1748-1090.1979.tb00570.x
Clinical use of whole genome sequencing for Mycobacterium tuberculosis 10.1186/s12916-016-0598-2
Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: A two site evaluation 10.1016/S1386-6532(01)00209-8
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence 10.1128/IAI.74.1.88-98.2006
Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission 10.1136/thorax.57.7.617
Development of an in vitro model of Toxoplasma gondii cyst formation 10.1111/j.1574-6968.1993.tb06593.x
Quantification of cytomegalovirus DNA in blood specimens from bone marrow transplant recipients by the polymerase chain reaction 10.1016/0166-0934(94)90077-9
Microarray analysis of whole genome expression of intracellular Mycobacterium tuberculosis 10.2174/156652407780598548
Increased transcription of a potential sigma factor regulatory gene Rv1364c in Mycobacterium bovis BCG while residing in macrophages indicates use of alternative promoters 10.1016/j.femsle.2004.02.028
Genomic analysis of Mycobacterium tuberculosis complex strains used for production of purified protein derivative 10.1128/JCM.41.8.3929-3932.2003
Lipid composition and transcriptional response of Mycobacterium tuberculosis grown under iron-limitation in continuous culture: Identification of a novel wax ester 10.1099/mic.0.2006/004317-0
Minisatellites corresponding to the human polycore probes 33.6 and 33.15 in the genome of the most 'primitive' known eukaryote Giardia lamblia 10.1016/0378-1119(95)00572-5
Determination of Mycobacterium leprae Viability by Polymerase Chain Reaction Amplification of 71-kDa Heat-Shock Protein mRNA 10.1093/infdis/168.3.799
Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes 10.1128/JB.188.2.669-676.2006
Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: Insights into the phagosomal environment 10.1084/jem.20030846
Point-of-care antibiotic susceptibility testing for gonorrhoea: Improving therapeutic options and sparing the use of cephalosporins 10.1136/sti.2010.044230
Kinetics of the in vitro gelation of a sickling haemoglobin from hog deer (Axis porcinus) 10.1016/0005-2795(79)90070-9
Evolutionary relationships among strains of Mycobacterium tuberculosis with few copies of IS6110 10.1128/JB.185.8.2555-2562.2003
Mycobacterium tuberculosis expresses two chaperonin-60 homologs 10.1073/pnas.90.7.2608
Microarray analysis of defined Mycobacterium tuberculosis populations using RNA amplification strategies 10.1186/1471-2164-9-94
Efficient translation and polyribosome binding of 125I-labelled rabbit globin messenger ribonucleoprotein 10.1016/0014-5793(83)80130-6
Microarrays for Mycobacterium tuberculosis 10.1016/j.tube.2004.01.002
Prevalence and clinical correlations of genetic subtypes of Giardia lamblia in an urban setting 10.1017/S0950268810000208
RNA profiling in host-pathogen interactions 10.1016/j.mib.2007.05.013
The in vitro model of tissue cyst formation in Toxoplasma gondii 10.1016/0169-4758(94)90148-1
Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy 10.1186/s12916-016-0609-3
Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin 10.1093/jac/dkn387
Professor D A Mitchison: 60 years of contributions to the chemotherapy of tuberculosis 10.1016/j.tube.2010.03.004
Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: Towards genotype-guided antimicrobial therapy 10.1093/jac/dkv432
High prevalence of antibiotic-resistant mycoplasma genitalium in nongonococcal urethritis: The need for routine testing and the inadequacy of current treatment options 10.1093/cid/cit752
An effective method of RNA extraction from bacteria refractory to disruption, including mycobacteria 10.1093/nar/25.3.675
Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock 10.1016/S0378-1097(97)00514-4
Genomic diversity among Beijing and non-Beijing Mycobacterium tuberculosis isolates from Myanmar 10.1371/journal.pone.0001973
Polyribosome binding of rabbit globin messenger RNA and messenger ribonucleoprotein labelled with bacteriophage-T4 RNA ligase and 5′-[32P] phosphocytidine 3′-phosphate 10.1093/nar/11.1.1
Recognition of tissue cyst-specific antigens in reactivating toxoplasmosis 10.1099/00222615-46-7-587
Contrasting transcriptional responses of a virulent and an attenuated strain of Mycobacterium tuberculosis infecting macrophages 10.1371/journal.pone.0011066
New strategies in microbiological diagnosis 10.1016/0195-6701(91)90017-3
Characterisation of bovine leukocyte ig-like receptors 10.1371/journal.pone.0034291
Quantitation of Toxoplasma gondii DNA in a competitive nested polymerase chain reaction 10.1136/jcp.52.1.61
Variation in Salmonella enterica serovar typhi IncHI1 plasmids during the global spread of resistant typhoid fever 10.1128/AAC.00645-08
Estimation of the rate of unrecognized cross-contamination with Mycobacterium tuberculosis in London Microbiology Laboratories 10.1128/JCM.40.11.4100-4104.2002
Use of DNA arrays to study transcriptional responses to antimycobacterial compounds. 10.1007/978-1-60327-279-7_6
DNA probes for the faecal diagnosis of Giardia lamblia infections in man 10.1042/bst0170363
The influence of reduced oxygen availability on pathogenicity and gene expression in Mycobacterium tuberculosis 10.1016/j.tube.2003.12.011
Oleoyl coenzyme a regulates interaction of transcriptional regulator RaaS (Rv1219c) with DNA in mycobacteria 10.1074/jbc.M114.577338
Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: A model for persistent organisms? 10.1016/j.tube.2003.12.010
Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling 10.4155/fmc.10.219
Characterization of the heat shock response in Mycobacterium bovis BCG 10.1128/jb.173.24.7982-7987.1991
Diagnosis of Pneumocystis carinii pneumonia: Immunofluorescence staining, simple PCR or nPCR 10.1016/S0163-4453(99)90106-8
Antimicrobial treatment improves mycobacterial survival in nonpermissive growth conditions 10.1128/AAC.02774-13
Extraction and characterization of mRNA from mycobacteria: implication for virulence gene identification 10.1016/0167-7012(91)90010-N
The use of DNA probes identifying restriction‐fragment‐length polymorphisms to examine the Mycobacterium avium complex 10.1111/j.1365-2958.1987.tb01934.x
An integrated whole genome analysis of Mycobacterium tuberculosis reveals insights into relationship between its genome, transcriptome and methylome 10.1038/s41598-019-41692-2
Platelet shape change: Induction by trypsin and release of an acidic macroglycopeptide from washed human platelets and from those of three cases of glanzmann’s thrombasthenia 10.1159/000214057
Diagnostic accuracy of a prototype rapid chlamydia and gonorrhoea recombinase polymerase amplification assay: a multicentre cross-sectional preclinical evaluation 10.1016/j.cmi.2018.06.003
Simon Waddell
Waddell Simon
ORCID: 0000-0002-3684-9116
Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase 10.1097/CCM.0b013e3182186d27
Mycobacterial P 1-Type ATPases mediate resistance to Zinc poisoning in human macrophages 10.1016/j.chom.2011.08.006
Methionine sulfoximine resistance in mycobacterium tuberculosis is due to a single nucleotide deletion resulting in increased expression of the major glutamine synthetase, GlnA1 10.1089/mdr.2010.0125
Intestinal injury and endotoxemia in children undergoing surgery for congenital heart disease 10.1164/rccm.201104-0715OC
Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs 10.1093/jac/dkq414
Distance-based differential analysis of gene curves 10.1093/bioinformatics/btr528
Use of DNA arrays to study transcriptional responses to antimycobacterial compounds. 10.1007/978-1-60327-279-7_6
Reprogramming the Mycobacterium tuberculosis transcriptome during pathogenesis 10.1016/j.ddmec.2010.09.007
Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling 10.4155/fmc.10.219
Contrasting transcriptional responses of a virulent and an attenuated strain of Mycobacterium tuberculosis infecting macrophages 10.1371/journal.pone.0011066
Benzothiazinones Kill Mycobacterium tuberculosis by blocking Arabinan synthesis 10.1126/science.1171583
Adjusting to a new home: Mycobacterium tuberculosis gene expression in response to an intracellular lifestyle 10.2217/fmb.09.94
Whole genome analysis using microarrays 10.1007/978-1-59745-207-6_6
Microarray analysis of defined Mycobacterium tuberculosis populations using RNA amplification strategies 10.1186/1471-2164-9-94
Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum 10.1371/journal.pmed.0050075
RNA profiling in host-pathogen interactions 10.1016/j.mib.2007.05.013
Quantification of global transcription patterns in prokaryotes using spotted microarrays 10.1186/gb-2007-8-12-r265
Microarray analysis of whole genome expression of intracellular Mycobacterium tuberculosis 10.2174/156652407780598548
Inactivation of polyketide synthase and related genes results in the loss of complex lipids in Mycobacterium tuberculosis H37Rv 10.1111/j.1472-765X.2005.01659.x
Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-γ 10.1172/JCI19316
The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds 10.1016/j.tube.2003.12.005
Increased transcription of a potential sigma factor regulatory gene Rv1364c in Mycobacterium bovis BCG while residing in macrophages indicates use of alternative promoters 10.1016/j.femsle.2004.02.028
Understanding anti-tuberculosis drug efficacy: Rethinking bacterial populations and how we model them 10.1016/j.ijid.2014.11.028
Potassium availability triggers Mycobacterium tuberculosis transition to, and resuscitation from, non-culturable (dormant) states 10.1098/rsob.140106
Oleoyl coenzyme a regulates interaction of transcriptional regulator RaaS (Rv1219c) with DNA in mycobacteria 10.1074/jbc.M114.577338
Antimicrobial treatment improves mycobacterial survival in nonpermissive growth conditions 10.1128/AAC.02774-13
Host-pathogen interactions 10.1007/978-1-4614-4966-9_6
Dissecting Interferon-Induced Transcriptional Programs in Human Peripheral Blood Cells 10.1371/journal.pone.0009753
Intracellular Microbe Whole-Genome Expression Profiling: Methodological Considerations and Biological Inferences 10.1002/9783527629176.ch9
Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages. 10.1371/journal.pone.0001403
Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy 10.1186/s12916-016-0609-3
Increased transcription of a potential sigma factor regulatory gene Rv1364c in Mycobacterium bovis BCG while residing in macrophages indicates use of alternative promoters 10.1111/j.1574-6968.2004.tb09500.x
A non-canonical mismatch repair pathway in prokaryotes 10.1038/ncomms14246
A Novel TetR-like transcriptional regulator is induced in acid-nitrosative stress and controls expression of an efflux pump in mycobacteria 10.3389/fmicb.2017.02039
Childhood tuberculosis is associated with decreased abundance of T cell gene transcripts and impaired T cell function 10.1371/journal.pone.0185973
Identification of ion-channel modulators that protect against aminoglycoside-induced hair cell death. 10.1172/jci.insight.96773
Transcriptional profiling Mycobacterium tuberculosis from patient sputa 10.1007/978-1-4939-7638-6_11
Design, Synthesis, and Biological Evaluation of a New Series of Carvedilol Derivatives That Protect Sensory Hair Cells from Aminoglycoside-Induced Damage by Blocking the Mechanoelectrical Transducer Channel 10.1021/acs.jmedchem.8b01325
Protein kinase B controls Mycobacterium tuberculosis growth via phosphorylation of the transcriptional regulator Lsr2 at threonine 112 10.1111/mmi.14398
Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan 10.1038/s41598-019-51562-6
The use of transcriptomics to predict drug efficacy and treatment outcome in tuberculosis 10.4155/9781910419144
Spontaneously Occurring Small-Colony Variants of Staphylococcus aureus Show Enhanced Clearance by THP-1 Macrophages. 10.3389/fmicb.2020.01300
cDNA-RNA subtractive hybridization reveals increased expression of mycocerosic acid synthase in intracellular Mycobacterium bovis BCG 10.1099/00221287-147-8-2293
Identification of antigens presented by MHC for vaccines against tuberculosis 10.1038/s41541-019-0148-y
Multi-omics technologies applied to tuberculosis drug discovery 10.3390/app10134629
Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis 10.1093/jac/dkaa307
Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux 10.3389/fmicb.2020.575828
Search for Antimicrobial Activity Among Fifty-Two Natural and Synthetic Compounds Identifies Anthraquinone and Polyacetylene Classes That Inhibit Mycobacterium tuberculosis 10.3389/fmicb.2020.622629
Weighted gene co-expression network analysis identifies key modules and hub genes associated with mycobacterial infection of human macrophages 10.3390/antibiotics10020097
Three-dimensional low shear culture of Mycobacterium bovis BCG induces biofilm formation and antimicrobial drug tolerance 10.1038/s41522-021-00186-8
Identification of a series of hair-cell MET channel blockers that protect against aminoglycoside-induced ototoxicity 10.1172/jci.insight.145704
Correction to: Lu et al. weighted gene co-expression network analysis identifies key modules and hub genes associated with mycobacterial infection of human macrophages. antibiotics 2021, 10, 97 10.3390/antibiotics10070792
Undetected carriage explains apparent Staphylococcus aureus acquisition in a non-outbreak healthcare setting 10.1016/j.jinf.2021.07.016
Evolving droplet dynamics during violent expiratory events at various ambient environments 10.1615/AtomizSpr.2021037116
Jakob Albrethsen
Albrethsen Jakob
ORCID: 0000-0002-2842-1128
Clinical proteomics: Insights from IGF-I. 10.1016/j.cca.2017.11.034
Mining the granule proteome: a potential source of endocrine biomarkers. 10.2217/bmm.14.107
Atrial natriuretic peptides in plasma. 10.1016/j.cca.2014.08.017
Adropin: a new regulatory peptide in cardiovascular endocrinology. 10.1016/j.regpep.2014.04.002
Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues. 10.1016/j.bbapap.2013.12.006
Proteomics of cancer cell lines resistant to microtubule-stabilizing agents. 10.1158/1535-7163.mct-13-0471
Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin-antitoxin systems. 10.1074/mcp.m112.018846
Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer. 10.1002/prca.201100095
Gel-based proteomics of liver cancer progression in rat. 10.1016/j.bbapap.2011.05.018
The first decade of MALDI protein profiling: a lesson in translational biomarker research. 10.1016/j.jprot.2011.02.027
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. 10.1074/mcp.m900546-mcp200
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. 10.1126/science.1171583
Evaluation of a type 1 diabetes serum cohort by SELDI-TOF MS protein profiling. 10.1002/prca.200800063
Unravelling the nuclear matrix proteome. 10.1016/j.jprot.2008.09.005
Reproducibility in protein profiling by MALDI-TOF mass spectrometry. 10.1373/clinchem.2006.082644
The Arabidopsis ADP-ribosylation factor (ARF) and ARF-like (ARL) system and its regulation by BIG2, a large ARF-GEF 10.1016/j.plantsci.2006.07.002
Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer. 10.1016/j.ejca.2006.05.039
Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum. 10.1515/cclm.2006.228
Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. 10.1186/1471-2407-5-8
FYVE zinc-finger proteins in the plant model Arabidopsis thaliana: identification of PtdIns3P-binding residues by comparison of classic and variant FYVE domains. 10.1042/0264-6021:3590165
Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum 10.1515/cclm-2018-0171
Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function. 10.1210/clinem/dgaa145
Longitudinal Increases in Serum Insulin-like Factor 3 and Testosterone Determined by LC-MS/MS in Pubertal Danish Boys 10.1210/clinem/dgaa496
Serum insulin-like factor 3 quantification by LC–MS/MS in male patients with hypogonadotropic hypogonadism and Klinefelter syndrome 10.1007/s12020-021-02609-0
Serum Insulin-like Factor 3 Levels Are Reduced in Former Androgen Users, Suggesting Impaired Leydig Cell Capacity 10.1210/clinem/dgab129
Neeraj Dhar
Dhar Neeraj
ORCID: 0000-0002-5887-8137
Dynamic Persistence of Antibiotic-Stressed Mycobacteria 10.1126/science.1229858
Mycobacterium tuberculosisEspB binds phospholipids and mediates EsxA-independent virulence 10.1111/mmi.12336
Single-cell dynamics of the chromosome replication and cell division cycles in mycobacteria 10.1038/ncomms3470
EspD Is Critical for the Virulence-Mediating ESX-1 Secretion System in Mycobacterium tuberculosis 10.1128/JB.06417-11
Malachite Green Interferes with Postantibiotic Recovery of Mycobacteria 10.1128/AAC.00406-12
Streptomycin-Starved Mycobacterium tuberculosis 18b, a Drug Discovery Tool for Latent Tuberculosis 10.1128/AAC.01125-12
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis 10.1126/scitranslmed.3004395
Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis 10.1016/j.vaccine.2011.07.039
Development of a repressible mycobacterial promoter system based on two transcriptional repressors 10.1093/nar/gkq235
Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice 10.1073/pnas.1003219107
Simple Model for Testing Drugs against Nonreplicating Mycobacterium tuberculosis 10.1128/AAC.00821-10
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 10.1126/science.1171583
Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs 10.1016/j.vaccine.2009.09.121
Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in Lung 10.1371/journal.pone.0003869
Microbial phenotypic heterogeneity and antibiotic tolerance 10.1016/j.mib.2006.12.007
Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis 10.1016/j.vaccine.2005.03.056
Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype 10.1111/j.1365-3083.2005.01569.x
Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis 10.1007/s00430-002-0170-x
Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs 10.1046/j.1365-2958.2003.03712.x
Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-Guerin 10.1046/j.1365-3083.2003.01321.x
Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system 10.1016/S0165-2478(03)00043-9
4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity 10.1021/jm5005978
Assessing the essentiality of the decaprenyl-phospho-D-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants 10.1111/mmi.12546
Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism 10.1038/ncomms4369
Dielectrophoresis-based purification of antibiotic-treated bacterial subpopulations 10.1039/c4lc00109e
In Vitro and In Vivo Activities of Three Oxazolidinones against Nonreplicating Mycobacterium tuberculosis 10.1128/AAC.02410-14
Phenotypic Profiling of Mycobacterium tuberculosis EspA Point Mutants Reveals that Blockage of ESAT-6 and CFP-10 Secretion In Vitro Does Not Always Correlate with Attenuation of Virulence 10.1128/JB.00967-13
Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis 10.1128/AAC.00528-15
2-carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1 10.1021/cb5007163
Rapid cytolysis of mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic 10.1128/AAC.03461
Stressed mycobacteria use the chaperone ClpB to sequester irreversibly oxidized proteins asymmetrically within and between cells 10.1016/j.chom.2014.12.008
Stress and host immunity amplify mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms 10.1016/j.chom.2014.11.016
Single-cell analysis of mycobacteria using microfluidics and time-lapse microscopy 10.1007/978-1-4939-2450-9_14
Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent mycobacterium tuberculosis 10.1128/AAC.03205-14
The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo 10.1128/JB.01346-13
EspI regulates the ESX-1 secretion system in response to ATP levels in Mycobacterium tuberculosis 10.1111/mmi.12718
Recombinant BCG approach for development of vaccines: Cloning and expression of immunodominant antigens of M. tuberculosis 10.1016/S0378-1097(00)00353-0
Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β- d -ribose Oxidase 10.1021/acsinfecdis.5b00065
Combinations of β-lactam antibiotics currently in clinical trials are efficacious in a dhp-i-deficient mouse model of tuberculosis infection 10.1128/AAC.01063-15
Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic 10.1128/AAC.03461-14
Erratum to The Phosphatidyl-myo-Inositol Mannosyltransferase PimA Is Essential for Mycobacterium tuberculosis Growth In Vitro and In Vivo [Journal of Bacteriology, 196, 19, (2014) 3441-3451] DOI: 10.1128/JB.02332-14 10.1128/JB.02332-14
Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor 10.1016/j.ebiom.2016.05.006
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535
An Amidase_3 domain-containing N-acetylmuramyl-L-alanine amidase is required for mycobacterial cell division 10.1038/s41598-017-01184-7
Division site selection linked to inherited cell surface wave troughs in mycobacteria 10.1038/nmicrobiol.2017.94
Elucidating the role of (p)ppGpp in mycobacterial persistence against antibiotics 10.1002/iub.1888
Preexisting variation in DNA damage response predicts the fate of single mycobacteria under stress 10.15252/embj.2019101876
Computational Analysis of the Mutual Constraints between Single‐Cell Growth and Division Control Models 10.1002/adbi.201900103
A lung-on-chip model reveals an essential role for alveolar epithelial cells in controlling bacterial growth during early tuberculosis 10.1101/2020.02.03.931170
Driving polar growth 10.7554/eLife.57043
Dielectrophoresis as a single cell characterization method for bacteria 10.1088/2057-1976/3/1/015005
Early invasion of uropathogenic Escherichia coli into the bladder wall by solitary bacteria that are protected from antibiotics and neutrophil swarms in an organoid model 10.1101/2020.10.29.358622
A lung-on-chip model of early Mycobacterium tuberculosis infection reveals an essential role for alveolar epithelial cells in controlling bacterial growth 10.7554/eLife.59961
Dynamic persistence of intracellular bacterial communities of uropathogenic Escherichia coli in a human bladder-chip model of urinary tract infections 10.1101/2021.01.03.424836
Rapid endotheliitis and vascular damage characterize SARS‐CoV‐2 infection in a human lung‐on‐chip model 10.15252/embr.202152744
Dynamic persistence of UPEC intracellular bacterial communities in a human bladder-chip model of urinary tract infection 10.7554/eLife.66481
Early invasion of the bladder wall by solitary bacteria protects UPEC from antibiotics and neutrophil swarms in an organoid model 10.1016/j.celrep.2021.109351
Jana Korduláková
Korduláková Jana
ORCID: 0000-0003-2834-0165
New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action 10.1016/j.ejmech.2018.04.017
Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria. 10.1074/jbc.ra117.000246
Mechanochemical synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity 10.3390/molecules22091457
Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression 10.1038/srep43495
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535
Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis 10.1016/j.ejmech.2016.07.028
Structural basis for selective recognition of acyl chains by the membrane-associated acyltransferase PatA 10.1038/ncomms10906
Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth 10.1016/j.ejmech.2015.06.035
DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization 10.1021/acschembio.5b00237
Lead selection and characterization of antitubercular compounds using the Nested Chemical Library 10.1016/j.tube.2015.02.028
Covalent Modification of the Mycobacterium tuberculosis FAS-II Dehydratase by Isoxyl and Thiacetazone 10.1021/id500032q
Erratum for Ang et al., An ethA-ethR-Deficient Mycobacterium bovis BCG Mutant Displays Increased Adherence to Mammalian Cells and Greater Persistence In Vivo, Which Correlate with Altered Mycolic Acid Composition. 10.1128/IAI.02884-14
Erratum for Boldrin et al., The Phosphatidyl-myo-Inositol Mannosyltransferase PimA Is Essential for Mycobacterium tuberculosis Growth In Vitro and In Vivo. 10.1128/JB.02332-14
The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo 10.1128/JB.01346-13
Purification and characterization of the acyltransferase involved in biosynthesis of the major mycobacterial cell envelope glycolipid--monoacylated phosphatidylinositol dimannoside. 10.1016/j.pep.2014.04.014
An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition 10.1128/IAI.01332-13
A small multidrug resistance-like transporter involved in the arabinosylation of arabinogalactan and lipoarabinomannan in mycobacteria 10.1074/jbc.M112.400986
A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone 10.1074/jbc.M112.400994
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane 10.1038/nchembio.794
Investigation of ABC transporter from mycobacterial arabinogalactan biosynthetic cluster 10.4149/gpb_2011_03_239
The structure-activity relationship of urea derivatives as anti-tuberculosis agents 10.1016/j.bmc.2011.07.034
Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ring 10.1016/j.ejmech.2010.09.048
Molecular Basis of Phosphatidyl-myo-inositol Mannoside Biosynthesis and Regulation in Mycobacteria 10.1074/jbc.R110.168328
AftD, a novel essential arabinofuranosyltransferase from mycobacteria 10.1093/glycob/cwp116
Substrate-induced conformational changes in the essential peripheral membrane-associated mannosyltransferase PimA from mycobacteria. Implications for catalysis 10.1074/jbc.M109.003947
Mycobacterial Epoxide Hydrolase EphD Is Inhibited by Urea and Thiourea Derivatives 10.3390/ijms22062884
Identification of the required acyltransferase step in the biosynthesis of the phosphatidylinositol mannosides of Mycobacterium species 10.1074/jbc.M303639200
Erratum: Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors (Journal of Medicinal Chemistry (2020) 63:9 (4749-4761) DOI: 10.1021/acs.jmedchem.0c00007) 10.1021/acs.jmedchem.0c01187
The Two-Component Locus MSMEG_0244/0246 Together With MSMEG_0243 Affects Biofilm Assembly in M. smegmatis Correlating With Changes in Phosphatidylinositol Mannosides Acylation 10.3389/fmicb.2020.570606
Crystallization and preliminary crystallographic analysis of PimA, an essential mannosyltransferase from Mycobacterium smegmatis 10.1107/S1744309105012364
Genetic basis for the biosynthesis of methylglucose lipopolysaccharides in Mycobacterium tuberculosis 10.1074/jbc.M702676200
Fragment-based design of mycobacterium tuberculosis inha inhibitors 10.1021/acs.jmedchem.0c00007
Trehalose Conjugation Enhances Toxicity of Photosensitizers against Mycobacteria 10.1021/acscentsci.8b00962
Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents 10.1016/j.chembiol.2019.02.013
Molecular recognition and interfacial catalysis by the essential phosphatidylinositol mannosyltransferase PimA from mycobacteria 10.1074/jbc.M702087200
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β- d -ribofuranose 2′-Oxidase 10.1021/acs.jmedchem.9b00912
Benzothiazinones Kill Mycobacterium tuberculosis by blocking Arabinan synthesis 10.1126/science.1171583
Alkylamino derivatives of N-benzylpyrazine-2-carboxamide: synthesis and antimycobacterial evaluation 10.1039/c5md00178a
Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis 10.1128/AAC.00433-07
New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053 10.1021/acsinfecdis.9b00388
Definition of the first mannosylation step in phosphatidylinositol mannoside synthesis: PimA is essential for growth of mycobacteria 10.1074/jbc.M204060200
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis 10.1371/journal.ppat.0030062
Identification of a novel galactosyl transferase involved in biosynthesis of the mycobacterial cell wall 10.1128/JB.00489-06
A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis 10.1021/acsinfecdis.0c00325
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 10.1021/acsinfecdis.0c00622
p-hydroxybenzoic acid synthesis in Mycobacterium tuberculosis 10.1074/jbc.M508332200
Silvia Buroni
Buroni Silvia
ORCID: 0000-0002-6979-2275
Email: silvia.buroni@unipv.it
Mycobacterium tuberculosis: Drug resistance and future perspectives 10.2217/fmb.09.20
Exploring the HME and HAE1 efflux systems in the genus Burkholderia 10.1186/1471-2148-10-164
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis 10.1126/scitranslmed.3004395
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain 10.1016/j.resmic.2004.08.011
Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms 10.1128/AAC.01571-10
Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target 10.2174/092986710791959693
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 10.1128/AAC.05270-11
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis 10.1021/cb500149m
Differential roles of rnd efflux pumps in antimicrobial drug resistance of sessile and planktonic burkholderia cenocepacia cells 10.1128/AAC.03800-14
Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo 10.1038/srep32487
A census of RND superfamily proteins in the Burkholderia genus 10.2217/fmb.13.50
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator 10.1128/JB.00631-09
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 10.1128/AAC.00656-06
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates 10.1089/mdr.2011.0019
Mycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: Biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesis 10.1371/journal.pone.0015494
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia 10.3389/fmicb.2015.00815
Benzothiazinones Kill Mycobacterium tuberculosis by blocking Arabinan synthesis 10.1126/science.1171583
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance 10.1186/1471-2180-9-200
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 10.1186/1471-2180-6-66
Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems 10.1371/journal.pone.0055112
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance 10.1111/j.1365-2958.2010.07277.x
The Crystal Structure of Burkholderia cenocepacia DfsA Provides Insights into Substrate Recognition and Quorum Sensing Fatty Acid Biosynthesis 10.1021/acs.biochem.6b00178
Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-d-ribofuranose 2′-oxidase DprE1 10.1021/ja211042r
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia 10.1128/AAC.02438-13
Deciphering the role of rnd efflux transporters in burkholderia cenocepacia 10.1371/journal.pone.0018902
Erratum: Antituberculars which target decaprenylphosphoryl-β-D- ribofuranose 2'-oxidase DprE1: State of art (Applied Microbiology and Biotechnology (2012) 94 (907-916) DOI: 10.1007/s00253-012-4013-4) 10.1007/s00253-012-4217-7
Antimicrobial activity of six essential oils against Burkholderia cepacia complex: Insights into mechanism(s) of action 10.2217/fmb-2017-0121
Antituberculars which target decaprenylphosphoryl-β-Dribofuranose 2′-oxidase DprE1: State of art 10.1007/s00253-012-4013-4
Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance 10.1186/s12864-017-4222-4
Biochemical characterization of glutamate Racemase - A new candidate drug target against Burkholderia cenocepacia infections 10.1371/journal.pone.0167350
Burkholderia cenocepacia infections in cystic fibrosis patients: Drug resistance and therapeutic approaches 10.3389/fmicb.2017.01592
The Effect of 2-Thiocyanatopyridine Derivative 11026103 on Burkholderia Cenocepacia: Resistance Mechanisms and Systemic Impact 10.3390/antibiotics8040159
Various Evolutionary Trajectories Lead to Loss of the Tobramycin-Potentiating Activity of the Quorum-Sensing Inhibitor Baicalin Hydrate in Burkholderia cenocepacia Biofilms 10.1128/AAC.02092-18
Phenylacetyl coenzyme a, not phenylacetic acid, attenuates CepIR-regulated virulence in Burkholderia cenocepacia 10.1128/AEM.01594-19
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection 10.1016/j.nano.2019.102113
Editorial: Evolution of Genetic Mechanisms of Antibiotic Resistance 10.3389/fgene.2019.00983
Investigating the mechanism of action of diketopiperazines inhibitors of the burkholderia cenocepacia quorum sensing synthase CepI: A site-directed mutagenesis study 10.3389/fphar.2018.00836
Quorum sensing as antivirulence target in cystic fibrosis pathogens 10.3390/ijms20081838
The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens 10.1016/j.ejmech.2020.112132
Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia 10.1016/j.tim.2019.12.005
Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ 10.1128/AAC.01231-18
Molecular Characterization of the Burkholderia cenocepacia dcw Operon and FtsZ Interactors as New Targets for Novel Antimicrobial Design 10.3390/antibiotics9120841
Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens 10.3390/antibiotics10070863
Antistaphylococcal Activity of the FtsZ Inhibitor C109 10.3390/pathogens10070886
Priscille Brodin
Brodin Priscille
ORCID: 0000-0003-0991-7344
Email: priscille.brodin@inserm.fr
How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011
Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227 10.3390/toxins9070227.
Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections 10.2217/nnm-2016-0364
Cyclodextrin-based nanocarriers containing a synergic drug combination: a potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030 10.1016/j.ijpharm.2017.05.030.
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism 10.1007/s00401-016-1652-z
Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005 10.1016/j.drudis.2017.05.005.
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535
Impact of pe_ pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis 10.3389/fcimb.2017.00137
LppM impact on the colonization of macrophages by Mycobacterium tuberculosis 10.1111/cmi.12619
Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129 10.1002/cyto.a.23129.
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420 10.1126/science.aag1006
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters 10.1039/c5ob02630j
Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro 10.1007/s00705-016-2771-5
Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization 10.1016/j.str.2016.07.009
Mycolactone The amazing analgesic mycobacterial toxin 10.1051/medsci/20163202007
STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection 10.1038/srep29297
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 10.1021/cb5007163
Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo 10.1371/journal.ppat.1004650
High content screening in chemical biology: overview and main challenges 10.1051/medsci/20153102016
High-Content Screening Technology Combined with a Human Granuloma Model as a New Approach To Evaluate the Activities of Drugs against Mycobacterium tuberculosis 10.1128/aac.03705-14
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system 10.1016/j.vaccine.2015.03.083
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro 10.3389/fmicb.2015.00438
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action 10.1128/jvi.01473-15
Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays 10.1007/978-1-4939-2450-9_24
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening 10.3791/51114
Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches 10.1021/jm500422b
Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways 10.1016/j.cell.2014.04.040
Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro 10.1016/j.jff.2014.09.022
A novel specific edge effect correction method for RNA interference screenings 10.1093/bioinformatics/btr648
Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis 10.1021/jm3003779
Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200825u
The Balance of Apoptotic and Necrotic Cell Death in Mycobacterium tuberculosis Infected Macrophages Is Not Dependent on Bacterial Virulence 10.1371/journal.pone.0047573
Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675
Ethionamide Boosters: Synthesis, Biological Activity, and Structure-Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200076a
High-content screening in infectious diseases 10.1016/j.cbpa.2011.05.023
Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ 10.1099/mic.0.038133-0
High Content Phenotypic Cell-Based Visual Screen Identifies Mycobacterium tuberculosis Acyltrehalose-Containing Glycolipids Involved in Phagosome Remodeling 10.1371/journal.ppat.1001100
High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery 10.4155/fmc.10.223
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting 10.1016/j.biomaterials.2009.09.044
Automated High-Throughput siRNA Transfection in Raw 264.7 Macrophages: A Case Study for Optimization Procedure 10.1177/1087057108328762
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 10.1126/science.1171583
High Content Screening Identifies Decaprenyl-Phosphoribose 2 ' Epimerase as a Target for Intracellular Antimycobacterial Inhibitors 10.1371/journal.ppat.1000645
Systematic Genetic Nomenclature for Type VII Secretion Systems 10.1371/journal.ppat.1000507
Control of M-tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP 10.1371/journal.ppat.0040033
Aquatic insects and transmission of Mycobacterium ulcerans 10.1051/medsci/20072367572
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity 10.1128/jb.00469-07
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis 10.1371/journal.ppat.0030062
Protection against mycobacterium ulcerans lesion development by exposure to aquatic insect saliva 10.1371/journal.pmed.0040064
Support vector machines for automatic detection of tuberculosis bacteria in confocal microscopy images 10.1109/isbi.2007.356794
Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues 10.1016/j.bmc.2006.12.009
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis 10.1128/iai.74.4.2128-2137.2006
Benzofuro 3,2-f 1 benzopyrans: A new class of antitubercular agents 10.1016/j.bmc.2006.03.033
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence 10.1128/iai.74.1.88-98.2006
High frequency of CD4(+) T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection 10.1128/iai.02086-05
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence 10.1128/jb.00631-06
Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis 10.1016/j.tube.2004.09.009
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity 10.1074/jbc.M503515200
Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0
Proteomic identification of M. tuberculosis protein kinase substrates: PknB recruits GarA, a FHA domain-containing protein, through activation loop-mediated interactions 10.1016/j.jmb.2005.05.049
Tuberculosis: from genome to vaccine 10.1586/14760584.4.4.541
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RDI immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6 10.1128/iai.72.4.2170-2176.2004
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens 10.1086/421468
ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007
Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex 10.1099/mic.0.26662-0
CD8(+)-T-cell responses of mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family 10.1128/iai.71.12.7173-7177.2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis 10.1038/nm859
A new evolutionary scenario for the Mycobacterium tuberculosis complex 10.1073/pnas.052548299
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant 10.1128/iai.70.10.5568-5578.2002
Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides 10.1021/bi015732y
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti 10.1046/j.1365-2958.2002.03237.x
6-Oxocytidine containing oligonucleotides inhibit the HIV-1 integrase in vitro 10.1081/ncn-100002322
Determinants of Mg2+-dependent activities of recombinant human immunodeficiency virus type 1 integrase 10.1021/bi000398b
Inhibition of the human immunodeficiency virus type 1 DNA integration by modified oligonucleotides 10.1023/a:1026631910681
Branched oligonucleotide-intercalator conjugate forming a parallel stranded structure inhibits HIV-1 integrase 10.1016/s0014-5793(99)01350-2
Inhibition of HIV-1 integration by mono- & bi-functionalized triple helix forming oligonucleotides 10.1080/07328319908044831
Optimization of alternate-strand triple helix formation at the 5 '-TpA-3 ' and 5 '-ApT-3 ' junctions 10.1093/nar/27.15.3029
A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus 10.1074/jbc.272.25.16010
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371 10.15252/embr.201744371.
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles 10.1038/s41598-017-05453-3
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4 10.1038/s41598-017-11843-4.
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays 10.1021/acschembio.7b00091
Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017 10.1016/j.mib.2017.11.017.
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020 10.1016/j.chom.2017.07.020. Epub 2017 Aug 31.
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101 10.1016/j.celrep.2017.08.101.
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114 10.1073/pnas.1707840114.
Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry 10.1128/jvi.01982-17
Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors 10.1016/j.celrep.2018.03.125
Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis 10.1016/j.bioorg.2018.08.025
Proteomics of Mycobacterium infection: Moving towards a Better Understanding of Pathogen-Driven immunomodulation 10.3389/fimmu.2018.00086
Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis 10.1128/aac.00359-18
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030
Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101
Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129
A fast, fully automated cell segmentation algorithm for high-throughput and high-content screening 10.1002/cyto.a.20627
Compartmentalized Encapsulation of Two Antibiotics in Porous Nanoparticles: an Efficient Strategy to Treat Intracellular Infections 10.1002/ppsc.201800360
Spatiotemporal Changes of the Phagosomal Proteome in Dendritic Cells in Response to LPS Stimulation 10.1074/mcp.RA119.001316
Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters 10.3389/fphar.2019.00378
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis 10.1021/acsnano.8b07902
Mitochondrial Dynamics and Activity in Legionella-Infected Cells 10.1007/978-1-4939-9048-1_13
Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria 10.3389/fmicb.2018.02258
Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication 10.1128/jvi.02009-18
A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluation 10.1039/C9OB00680J
Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls 10.3390/toxins11090516
Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies. 10.3389/fimmu.2020.569127
Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity. 10.1021/acsinfecdis.9b00277
Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds. 10.1371/journal.pone.0227224
Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis. 10.1016/j.vaccine.2019.11.085
IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551
Worms' Antimicrobial Peptides. 10.3390/md17090512
Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture. 10.1371/journal.pone.0198226
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38
Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570
Cell microbiology interview 10.1111/cmi.13288
Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts 10.1099/mgen.0.000505
Nathalie deboosere
deboosere Nathalie
ORCID: 0000-0002-2873-5485
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. 10.15252/embr.201744371
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling. 10.1016/j.celrep.2017.08.101
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227
Phenotypic assays for Mycobacterium tuberculosis infection. 10.1002/cyto.a.23129
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays. 10.1021/acschembio.7b00091
STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection. 10.1038/srep29297
LppM impact on the colonization of macrophages by Mycobacterium tuberculosis. 10.1111/cmi.12619
A microscopic phenotypic assay for the quantification of intracellular mycobacteria adapted for high-throughput/high-content screening. 10.3791/51114
Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces. 10.1016/j.fm.2012.04.007
Viral elution and concentration method for detection of influenza A viruses in mud by real-time RT-PCR. 10.1016/j.jviromet.2011.10.013
Comparison of chlorine and peroxyacetic-based disinfectant to inactivate Feline calicivirus, Murine norovirus and Hepatitis A virus on lettuce. 10.1016/j.ijfoodmicro.2011.08.011
Direct detection of highly pathogenic avian influenza A/H5N1 virus from mud specimens. 10.1016/j.jviromet.2011.06.002
Development and validation of a concentration method for the detection of influenza a viruses from large volumes of surface water. 10.1128/aem.02484-10
A predictive microbiology approach for thermal inactivation of Hepatitis A virus in acidified berries. 10.1016/j.fm.2010.05.018
Assessment of the removal and inactivation of influenza viruses H5N1 and H1N1 by drinking water treatment. 10.1016/j.watres.2010.01.013
Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables. 10.1016/j.ijfoodmicro.2005.11.007
Modelling effect of physical and chemical parameters on heat inactivation kinetics of hepatitis A virus in a fruit model system. 10.1016/j.ijfoodmicro.2003.10.015
Host-pathogen systems for early drug discovery against tuberculosis. 10.1016/j.mib.2017.11.017
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids. 10.1073/pnas.1707840114
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis. 10.1038/s41598-017-11843-4
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages. 10.1016/j.chom.2017.07.020
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles. 10.1038/s41598-017-05453-3
Host-directed therapies offer novel opportunities for the fight against tuberculosis. 10.1016/j.drudis.2017.05.005
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs. 10.1016/j.ijpharm.2017.05.030
Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis. 10.3389/fcimb.2017.00137
Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections. 10.2217/nnm-2016-0364
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. 10.1126/science.aag1006
How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. 10.1007/s00401-016-1652-z
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria. 10.1111/mmi.13535
Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization. 10.1016/j.str.2016.07.009
Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro. 10.1007/s00705-016-2771-5
[Mycolactone: the amazing analgesic mycobacterial toxin]. 10.1051/medsci/20163202007
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters. 10.1039/c5ob02630j
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. 10.1128/jvi.01473-15
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. 10.1016/j.vaccine.2015.03.083
Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo. 10.1371/journal.ppat.1004650
[High content screening in chemical biology: overview and main challenges]. 10.1051/medsci/20153102016
Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays. 10.1007/978-1-4939-2450-9_24
2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1. 10.1021/cb5007163
High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis. 10.1128/aac.03705-14
Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. 10.1016/j.cell.2014.04.040
Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches. 10.1021/jm500422b
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262
The balance of apoptotic and necrotic cell death in Mycobacterium tuberculosis infected macrophages is not dependent on bacterial virulence. 10.1371/journal.pone.0047573
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g
Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200825u
A novel specific edge effect correction method for RNA interference screenings. 10.1093/bioinformatics/btr648
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. 10.1371/journal.pone.0026675
High-content screening in infectious diseases. 10.1016/j.cbpa.2011.05.023
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200076a
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38
High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. 10.1371/journal.ppat.1001100
High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. 10.4155/fmc.10.223
Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ. 10.1099/mic.0.038133-0
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. 10.1371/journal.ppat.1000645
Systematic genetic nomenclature for type VII secretion systems. 10.1371/journal.ppat.1000507
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. 10.1016/j.biomaterials.2009.09.044
Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. 10.1126/science.1171583
Automated high-throughput siRNA transfection in raw 264.7 macrophages: a case study for optimization procedure. 10.1177/1087057108328762
Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. 10.1371/journal.ppat.0040033
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. 10.1128/jb.00469-07
[Aquatic insects and transmission of Mycobacterium ulcerans]. 10.1051/medsci/20072367572
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 10.1371/journal.ppat.0030062
Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. 10.1371/journal.pmed.0040064
Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues. 10.1016/j.bmc.2006.12.009
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. 10.1128/jb.00631-06
High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. 10.1128/iai.02086-05
Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents. 10.1016/j.bmc.2006.03.033
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. 10.1128/iai.74.4.2128-2137.2006
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. 10.1128/iai.74.1.88-98.2006
Tuberculosis: from genome to vaccine. 10.1586/14760584.4.4.541
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. 10.1074/jbc.m503515200
Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. 10.1099/mic.0.27799-0
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. 10.1016/j.tube.2004.09.009
ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. 10.1086/421468
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. 10.1128/iai.72.4.2170-2176.2004
Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex. 10.1099/mic.0.26662-0
CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. 10.1128/iai.71.12.7173-7177.2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. 10.1038/nm859
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. 10.1046/j.1365-2958.2002.03237.x
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. 10.1128/iai.70.10.5568-5578.2002
Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides. 10.1021/bi015732y
IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551
Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology 10.1101/2021.06.30.450483
Claudia Sala
Sala Claudia
ORCID: 0000-0003-4031-4648
Rv3852 (H-NS) of Mycobacterium tuberculosis Is Not Involved in Nucleoid Compaction and Virulence Regulation. 10.1128/jb.00129-17
Transcription facilitated genome-wide recruitment of topoisomerase I and DNA gyrase 10.1371/journal.pgen.1006754
Mycobacterium ulcerans mouse model refinement for pre-clinical profiling of vaccine candidates 10.1371/journal.pone.0167059
EspC forms a filamentous structure in the cell envelope of Mycobacterium tuberculosis and impacts ESX-1 secretion 10.1111/mmi.13575
The inosine monophosphate dehydrogenase, GuaB2, is a vulnerable new bactericidal drug target for tuberculosis 10.1021/acsinfecdis.6b00102
Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis. 10.1128/aac.01523-16
Genomic and transcriptomic analysis of the streptomycin-dependent Mycobacterium tuberculosis strain 18b 10.1186/s12864-016-2528-2
GtrA Protein Rv3789 Is Required for Arabinosylation of Arabinogalactan in Mycobacterium tuberculosis. 10.1128/jb.00628-15
Lansoprazole is an antituberculous prodrug targeting cytochrome bc1. 10.1038/ncomms8659
Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1 10.1016/j.chom.2015.05.003
Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis. 10.1128/aac.00528-15
Whole-transcriptome sequencing for high-resolution transcriptomic analysis in Mycobacterium tuberculosis 10.1007/978-1-4939-2450-9_2
Whole-genome sequencing for comparative genomics and de novo genome assembly 10.1007/978-1-4939-2450-9_1
Erratum for Boldrin et al., The Phosphatidyl-myo-Inositol Mannosyltransferase PimA Is Essential for Mycobacterium tuberculosis Growth In Vitro and In Vivo. 10.1128/jb.02332-14
Anticytolytic screen identifies inhibitors of mycobacterial virulence protein secretion 10.1016/j.chom.2014.09.008
Assessing essentiality of transketolase in Mycobacterium tuberculosis using an inducible protein degradation system 10.1111/1574-6968.12536
EspI regulates the ESX-1 secretion system in response to ATP levels in Mycobacterium tuberculosis 10.1111/mmi.12718
The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo. 10.1128/jb.01346-13
The PhoP-Dependent ncRNA Mcr7 Modulates the TAT Secretion System in Mycobacterium tuberculosis 10.1371/journal.ppat.1004183
In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis. 10.1128/aac.02410-14
Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants 10.1111/mmi.12546
High-resolution transcriptome and genome-wide dynamics of RNA polymerase and NusA in Mycobacterium tuberculosis 10.1093/nar/gks1260
High-resolution detection of DNA binding sites of the global transcriptional regulator GlxR in Corynebacterium glutamicum 10.1099/mic.0.062059-0
Towards a new tuberculosis drug: Pyridomycin - nature's isoniazid 10.1002/emmm.201201689
Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis. 10.1128/aac.01125-12
Virulence regulator EspR of mycobacterium tuberculosis is a nucleoid-associated protein 10.1371/journal.ppat.1002621
Genome-wide definition of the SigF regulon in Mycobacterium tuberculosis. 10.1128/jb.06692-11
Tuberculosis drugs: New candidates and how to find more 10.2217/fmb.11.46
Sigma factor F does not prevent rifampin inhibition of RNA polymerase or cause rifampin tolerance in Mycobacterium tuberculosis. 10.1128/jb.00687-10
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis. 10.1128/aac.00821-10
Transcriptional regulation of lipid homeostasis in mycobacteria 10.1111/j.1365-2958.2010.07313.x
Development of a repressible mycobacterial promoter system based on two transcriptional repressors 10.1093/nar/gkq235
Dissecting Regulatory Networks in Host-Pathogen Interaction Using ChIP-on-chip Technology 10.1016/j.chom.2009.04.007
Benzothiazinones Kill Mycobacterium tuberculosis by blocking Arabinan synthesis 10.1126/science.1171583
Genome-wide regulon and crystal structure of BlaI (Rv1846c) from Mycobacterium tuberculosis 10.1111/j.1365-2958.2008.06583.x
The katG mRNA of Mycobacterium tuberculosis and Mycobacterium smegmatis is processed at its 5′ end and is stabilized by both a polypurine sequence and translation initiation 10.1186/1471-2199-9-33
Bacteriophage P4 sut1: A mutation suppressing transcription termination 10.1099/vir.0.82605-0
DNA replication in phage P4: Characterization of replicon II 10.1016/j.plasmid.2006.06.004
Expression of phage P4 integrase is regulated negatively by both Int and Vis 10.1099/vir.0.81875-0
Mycobacterium tuberculosis FurA autoregulates its own expression. 10.1128/jb.185.18.5357-5362.2003
Transcriptional regulation of furA and katG upon oxidative stress in Mycobacterium smegmatis. 10.1128/jb.183.23.6801-6806.2001
Promoter mutagenesis for fine-tuning expression of essential genes in Mycobacterium tuberculosis 10.1111/1751-7915.12875
Essential Nucleoid Associated Protein mIHF (Rv1388) Controls Virulence and Housekeeping Genes in Mycobacterium tuberculosis 10.1038/s41598-018-32340-2
EspL is essential for virulence and stabilizes EspE, EspF and EspH levels in Mycobacterium tuberculosis 10.1371/journal.ppat.1007491
Polarly Localized EccE1 Is Required for ESX-1 Function and Stabilization of ESX-1 Membrane Proteins in Mycobacterium tuberculosis 10.1128/jb.00662-19
Host-Directed Therapies and Anti-Virulence Compounds to Address Anti-Microbial Resistant Tuberculosis Infection 10.3390/app10082688
FasR regulates fatty acid biosynthesis and is essential for virulence of Mycobacterium tuberculosis 10.1101/2020.06.08.140004
Advanced quantification methods to improve the 18b dormancy model for assessing the activity of tuberculosis drugs in vitro. 10.1128/aac.00280-20
Editorial on Special Issue “Tuberculosis Drug Discovery and Development 2019” 10.3390/app10176069
Multicenter analysis of sputum microbiota in tuberculosis patients 10.1371/journal.pone.0240250
Vaccines as remedy for antimicrobial resistance and emerging infections 10.1016/j.coi.2020.09.003
Antibodies, epicenter of SARS-CoV-2 immunology 10.1038/s41418-020-00711-w
FasR Regulates Fatty Acid Biosynthesis and Is Essential for Virulence of Mycobacterium tuberculosis 10.3389/fmicb.2020.586285
Vadim Makarov
Makarov Vadim / Vadim A. Makarov
ORCID: 0000-0001-8746-2694
Per aspera ad astra: Application of Simplex QSAR approach in antiviral research 10.4155/fmc.10.194
New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3 10.1016/j.antiviral.2008.09.002
Structure-based drug design and characterization of sulfonyl-piperazine benzothiazinone inhibitors of DprE1 from mycobacterium tuberculosis 10.1128/AAC.00681-18
The 8-pyrrole-benzothiazinones are noncovalent inhibitors of DprE1 from Mycobacterium tuberculosis 10.1128/AAC.00778-15
New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis 10.1371/journal.ppat.1008270
Benzothiazinones: Prodrugs that covalently modify the decaprenylphosphoryl- β-D-ribose 2′-epimerase DprE1 of mycobacterium tuberculosis 10.1021/ja106357w
Identification of novel small-molecule histone deacetylase inhibitors by medium-throughput screening using a fluorigenic assay 10.1042/BJ20080536
Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review) 10.1016/j.ejmech.2020.113014
Cmr is a redox-responsive regulator of DosR that contributes to M. tuberculosis virulence 10.1093/nar/gkx406
Binding of a N,N′-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families 10.1016/S0042-6822(03)00166-1
Benzothiazinones Kill Mycobacterium tuberculosis by blocking Arabinan synthesis 10.1126/science.1171583
Role of heparin and tissue type plasminogen activator in high altitude adaptation of the hemostasis system 10.1007/BF00840421
Synthesis of derivatives of a new heterocyclic system pyrazolo[3,4-b] pyrido[1′,2′: 1,2]imidazo[4,5-d]pyridine 10.1007/s11172-006-0322-z
Metabolic pathways of dithiocarbamates from laboratory powder diffraction data 10.1107/S0108270100013457
Synthesis of derivatives of pyrazolo[3,4-d]pyrimidines by reaction of 3,5-bis(dimethylaminomethylene)amino-4-methoxycarbonylpyrazole and 4-cyanopyrazole with amines 10.1023/A:1023780710982
Benzoylphenyl thiocyanates are new, effective inhibitors of the mycobacterial resuscitation promoting factor B protein 10.1186/s12941-017-0244-7
Development of macozinone for TB treatment: An update 10.3390/app10072269
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia 10.1128/AAC.02438-13
Synthesis and NMR spectroscopic study of derivatives of pyrazolo[1,5-a]pyrimidines 10.1007/BF02291935
The effect of 2-thiocyanatopyridine derivative 11026103 on Burkholderia Cenocepacia: Resistance mechanisms and systemic impact 10.3390/antibiotics8040159
Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication 10.1093/jac/dki055
Specific Antiviral Activity of Pyrimidinedispirotripiperazinium Alone and in Combination with Acyclovir on a Herpes-Simplex-Virus Infection Model 10.1007/s11094-019-02079-9
4-dialkyldithiocarbamoyl-5-nitropyrimidines. Synthesis, structure, properties 10.1007/BF01184891
Highly polarized enamines. 3. Study of the spatial structure of α,α-diamino-β-cyano-β-nitroethylene derivatives 10.1007/BF02290751
Multiple Machine Learning Comparisons of HIV Cell-based and Reverse Transcriptase Data Sets 10.1021/acs.molpharmaceut.8b01297
Investigating the mechanism of action of diketopiperazines inhibitors of the burkholderia cenocepacia quorum sensing synthase CepI: A site-directed mutagenesis study 10.3389/fphar.2018.00836
Mycobacterium abscessus, an emerging and worrisome pathogen among cystic fibrosis patients 10.3390/ijms20235868
Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae 10.1038/srep27156
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia 10.3389/fmicb.2020.00562
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis 10.1021/cb500149m
3,12-Diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride from X-ray powder data 10.1107/S0108270199004138
The evolution of pleconaril: Modified o-alkyl linker analogs have biological activity towards coxsackievirus B3 Nancy 10.3390/molecules25061345
Study of the hemostatic properties of gaseous ozone 10.1007/BF02444668
Molecular determinants of inactivation of the resuscitation promoting factor B from Mycobacterium tuberculosis 10.1080/07391102.2012.698243
Synthesis, cytotoxicity and antiviral activity of N,N′-bis-5-nitropyrimidyl derivatives of dispirotripiperazine 10.1016/S0166-3542(02)00014-1
Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket 10.1016/j.antiviral.2015.09.009
4-(N,N-Dialkylthiocarbamoylthio)-5-nitropyrimidines as new potential nitric oxide donors 10.1007/s11172-006-0203-5
New targets for HIV drug discovery 10.1016/j.drudis.2019.03.013
Mechanism of action of 5-nitrothiophenes against mycobacterium tuberculosis 10.1128/AAC.02693-13
Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus 10.1128/JVI.00998-07
In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis 10.1371/journal.pntd.0004022
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance 10.1111/j.1365-2958.2010.07277.x
Study of antileprosy activities of some dialkyldithiocarbamate derivatives 10.1007/s10517-007-0111-1
Reactions of 4(6)-chloro-5-nitropyrimidines with nucleophilic agents (review) 10.1007/BF00810974
Synthesis and Some Biological Properties of Pyrrolo[1,2-a]indoles 10.1002/jhet.2312
3,5-Bis[(N,N-dimethylamino)methyleneamino]-1-methyl-4-nitropyrazole from X-ray powder diffraction data 10.1107/S010827010000860X
The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens 10.1016/j.ejmech.2020.112132
Antileprosy activity and preliminary toxicological characteristics of some dialkyldithiocarbamate derivatives 10.1007/s10517-008-0114-6
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 10.3389/fmicb.2020.00292
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 10.1021/acsinfecdis.0c00622
Synthesis and properties of β,β-bisfunctionalised ketene N,N-acetals 10.1070/RC1998v067n11ABEH000422
Disturbance of antithrombogenic activity of the vessel wall in malignancy 10.1007/BF00791512
The past, present and future of RNA respiratory viruses: Influenza and coronaviruses 10.1093/femspd/ftaa046
How to kill dormant Mycobacterium tuberculosis 10.4103/ijmy.ijmy_106_18
Investigation of bisheteryl derivatives of piperazine and its analogs. 2. Synthesis and properties of bis(dialkyldithiocarbamoyl-5-nitro-4-pyrimidyl)piperazines 10.1007/BF01169676
WIN compounds: on the way to efficient antipicornaviral agent. A historical survey 10.1007/s11172-020-2811-x
Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site 10.1073/pnas.1904732116
4,5-Diamino-1-phenyl-1,7-dihydro-6H-pyrazolo[3,4-b]pyridin-6-one in the synthesis of fused tricyclic systems 10.1007/s11172-007-0369-5
Intermolecular -CH3⋯O2N- contacts in two polymorphic modifications of (1E)-N′-[(E)-2-cyano-1-(dimethylamino)-2- nitrovinyl]-N,N-dimethylethanimidamide 10.1107/S0108768103010231
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans 10.1038/s41598-017-09177-2
QSAR analysis of [(biphenyloxy)propyl] isoxazoles: Agents against coxsackievirus B3 10.4155/fmc.10.278
Synthesis of pyrazolo [1,5-a] pyrimidines by the reaction of β-dicarbonyl compounds with 3,5-diamino-4-nitropyrazole 10.1007/BF02317814
Conversion of 4-chloro-5-nitropyrimidines to 1,3,5-triazines using alkylisothioureas 10.1007/BF00476222
Reaction of 3,5-diamino-4-nitropyrazole with electrophilic reagents 10.1007/BF02253106
Investigation of the reaction of 3,5-diamidino-4-nitropyrazole with amines 10.1023/A:1020921530209
Synthesis of Modified Peptides with C-Terminal α-Amino Aldehydes 10.1023/A:1011365401976
Transformations of ortho-methoxyaryl(hetaryl)carboxamides into quinazolin-4-one and pyrido[2,3-d]pyrimidin-4-one derivatives 10.1007/s11172-006-0057-x
Structural characterization of prazosin hydrochloride and prazosin free base 10.1002/jps.20204
Crystal and molecular structure of 1-amino-4-methoxycarbonyl-3-methyl-8-oxopyrazolo[1,5-a]pyrimidine monohydrate from laboratory powder data 10.1017/S0885715600010708
Copper-related toxicity in replicating and dormant Mycobacterium tuberculosis caused by 1-hydroxy-5-R-pyridine-2(1H)-thiones 10.1039/c8mt00067k
Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo 10.1038/srep32487
Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ 10.1128/AAC.01231-18
Highly polarized enamines. 4. Unusual transformation of α,α-diamino-β-cyano-β-nitroethylene derivatives into 4,6-bisdimethylamino-5-nitropyrimidine 10.1007/BF02253108
Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses 10.1016/j.ejmech.2019.06.008
Anti-coxsackievirus B3 activity of 2-amino-3-nitropyrazolo[1,5-a] pyrimidines and their analogs 10.1016/j.bmcl.2004.10.043
Nitric oxide-releasing compounds for the treatment of lung infections 10.1016/j.drudis.2020.10.027
Amphiphilic star-shaped block copolymers as unimolecular drug delivery systems: Investigations using a novel fungicide 10.1039/c2sm26509e
Resuscitation-promoting Factors (Rpf): In Search of Inhibitors 10.2174/092986612802762723
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 10.1038/s41598-018-21614-4
A rapid method for estimation of the efficacy of potential antimicrobials in humans and animals by agar diffusion assay 10.1111/cbdd.13427
Synthesis and thermal transformations of 5-nitropyrimidin-4-yl dialkyldithiocarbamates 10.1023/B:RUCB.0000037858.17011.fb
The redox state regulates the conformation of Rv2466c to activate the antitubercular prodrug TP053 10.1074/jbc.M115.677039
Identification of individual structural fragments of N,N′-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds 10.1093/jac/dkm172
Study of the reaction of 3,5-diamino-4-carbomethoxypyrazole with acetoacetic ester. Synthesis of pyrazolo[1,5-a]pyrimidine 10.1007/BF02256848
Synthesis of pyrazolo[1,5-a]-pyrimidines by reaction of 3,5-diamino-4-nitropyrazole with acetoacetic ester in the presence of alkaline agents 10.1007/BF02256847
The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis 10.1074/jbc.M117.797837
Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma 10.1371/journal.pone.0217139
Different influence of thrombolytic and physiological doses of single-chain urokinase-type plasminogen activator on washed platelets aggregation 10.1016/s0268-9499(96)80467-x
Finding of the low molecular weight inhibitors of resuscitation promoting factor enzymatic and resuscitation activity 10.1371/journal.pone.0008174
Crystal and molecular structures of 2-[1-(2-aminoethyl)-2-imidazolidinylidene]-2-nitroacetonitrile (C7H11N5O2) and 2,6-diamino-5-hydroxy-3-nitro-4H-pyrazolo[1,5-a]-pyrimidin-7-one monohydrate (C6H6N6O4·H2O) from X-ray, synchrotron and neutron powder diffraction data 10.1107/S010876819900213X
The in vivo environment accelerates generation of resuscitation-promoting factor-dependent mycobacteria 10.1164/rccm.201407-1289LE
Stable enhancement of tissue-type plasminogen activator levels in blood: Interrupted chamber hypoxia mimics effects of alpine hypoxia 10.1016/0268-9499(94)90254-2
New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis 10.1016/j.jiac.2017.04.012
Transformations of 5-nitropyrimidines 10.1002/jhet.5570450301
Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: Antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment 10.1093/jac/dki263
DSTP-27 prevents entry of human cytomegalovirus 10.1128/AAC.01964-13
Optimized background regimen for treatment of active tuberculosis with the next-generation benzothiazinone macozinone (PBTZ169) 10.1128/AAC.00840-18
Towards a new combination therapy for tuberculosis with next generation benzothiazinones 10.1002/emmm.201303575
Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication 10.1021/jm0704806
Enamines as Synthons in the Synthesis of Heterocycles 10.1016/S0065-2725(08)60318-9
Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones 10.1128/AAC.01676-09
Synthesis and antileprosy activity of some dialkyldithiocarbamates 10.1093/jac/dkl095
6,11-Dioxobenzo[ f]pyrido[1,2- a]indoles Kill Mycobacterium tuberculosis by Targeting Iron-Sulfur Protein Rv0338c (IspQ), A Putative Redox Sensor 10.1021/acsinfecdis.0c00531
DprE1 - from the discovery to the promising tuberculosis drug target 10.2174/138161282027140630122724
Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses 10.1016/j.ejmech.2019.112007
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia 10.3389/fmicb.2015.00815
New 2-Thiopyridines as potential candidates for killing both actively growing and dormant mycobacterium tuberculosis cells 10.1128/AAC.01308-13
Highly polarized enamines. 2. Synthesis and investigation of the further amination of derivatives of α,α-diamino-β-cyano-β-nitroethylene 10.1007/BF01164870
Fluorescent Benzothiazinone Analogues Efficiently and Selectively Label Dpre1 in Mycobacteria and Actinobacteria 10.1021/acschembio.8b00790
Highly polarized enamines 1. synthesis and some properties of β-tetrazolylenamines 10.1007/BF01169644
Investigation of bis-heteryl derivatives of piperazine and its analogs 1. Synthesis and conversions of n,n′-bis(2-r-5-nitro-6-pyrimidinyl)piperazines and n,n3-bis(2-r-5-nitro-6-pyrimidinyl)dispirotripiperazinium dichloride 10.1007/BF01169643
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG 10.1016/j.chembiol.2015.05.016
Furoxanopyrimidines as exogenous donors of nitric oxide 10.1023/A:1022446208137
Antiretroviral activity of a novel pyrimidyl-di(Diazaspiroalkane) derivative 10.32607/20758251-2017-9-1-105-107
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection 10.1016/j.nano.2019.102113
Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis 10.1021/acs.jmedchem.9b02075
Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses 10.1002/cmdc.201500304
Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-d-ribofuranose 2′-oxidase DprE1 10.1021/ja211042r
New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053 10.1021/acsinfecdis.9b00388
2-carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1 10.1021/cb5007163
Synthesis of pyrazolo[3,4-b]pyridin-6-ones 10.1002/jhet.986
Pipeline of anti‐ Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities 10.1002/med.21798
Roland Brosch
Brosch Roland
ORCID: 0000-0003-2587-3863
Mycobacterium tuberculosis Meets the Cytosol: The Role of cGAS in Anti-mycobacterial Immunity. 10.1016/j.chom.2015.05.017
Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii 10.1093/gbe/evv035
Mycobacterial Pathogenomics and Evolution. 10.1128/microbiolspec.MGM2-0025-2013
Release of mycobacterial antigens 10.1111/imr.12251
Mycobacterium abscessus phospholipase C expression is induced during coculture within amoebae and enhances M. abscessus virulence in mice 10.1128/IAI.02032-14
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system 10.1016/j.vaccine.2015.03.083
Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations 10.1038/srep15443
ESX/type VII secretion systems of mycobacteria: Insights into evolution, pathogenicity and protection 10.1016/j.tube.2015.02.019
Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014 10.1016/j.vaccine.2015.03.056
Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo 10.1371/journal.ppat.1004650
Bovine tubercle bacilli: evolution associated with loss of transmission capacity in humans | Les bacilles de la tuberculose bovine - Une évolution aux dépens de la transmissibilité chez l'homme 10.1051/medsci/20153102003
Mycobacterium tuberculosis Exploits Asparagine to Assimilate Nitrogen and Resist Acid Stress during Infection 10.1371/journal.ppat.1003928
Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development 10.2217/fmb.14.70
Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator 10.1073/pnas.1406693111
Bacillus calmette-guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy 10.1016/j.eururo.2014.02.061
A Specific polymorphism in Mycobacterium tuberculosis H37Rv causes differential ESAT-6 expression and identifies whiB6 as a novel ESX-1 component 10.1128/IAI.01824-14
A glimpse into the past and predictions for the future: The molecular evolution of the tuberculosis agent 10.1111/mmi.12720
TBCAP; Tuberculosis annotation project 10.1016/j.tube.2012.11.013
Identification and characterization of the genetic changes responsible for the characteristic smooth-to-rough morphotype alterations of clinically persistent Mycobacterium abscessus 10.1111/mmi.12387
Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis 10.1038/ng.2517
ESX-1-induced apoptosis is involved in cell-to-cell spread of Mycobacterium tuberculosis 10.1111/cmi.12169
Characterization of Mycobacterium orygis 10.3201/eid1903.121005
The ESX-5 Associated eccB5-eccC5 Locus Is Essential for Mycobacterium tuberculosis Viability 10.1371/journal.pone.0052059
Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion-encoded PE-PPE proteins predicts vaccine potential 10.1016/j.chom.2012.03.003
Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death 10.1371/journal.ppat.1002507
Multidrug-resistant tuberculosis in admitted patients at a tertiary referral hospital of Bangladesh 10.1371/journal.pone.0040545
Molecular epidemiology of tuberculosis in rural Matlab, Bangladesh 10.5588/ijtld.11.0426
ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria 10.1111/j.1462-5822.2012.01799.x
ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells 10.4161/auto.20881
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation 10.1111/j.1365-2958.2012.08001.x
Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies 10.3201/eid1804.110888
Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis 10.1002/eji.201141548
p62 and NDP52 proteins target intracytosolic Shigella and Listeria to different autophagy pathways 10.1074/jbc.M111.223610
Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent mycobacterial variants 10.1111/j.1462-5822.2010.01565.x
ESAT-6 secretion-independent impact of ESX-1 genes espF and espG 1on virulence of Mycobacterium tuberculosis 10.1093/infdis/jiq089
Deciphering the role of IS6110 in a highly transmissible Mycobacterium tuberculosis Beijing strain, GC1237 10.1016/j.tube.2010.12.007
Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ring 10.1016/j.ejmech.2010.09.048
High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling 10.1371/journal.ppat.1001100
Entrapment of intracytosolic bacteria by septin cage-like structures 10.1016/j.chom.2010.10.009
Systematic genetic nomenclature for type VII secretion systems 10.1371/journal.ppat.1000507
Pathogenomics of mycobacteria 10.1159/000235772
Pathogenicity in the tubercle bacillus: Molecular and evolutionary determinants 10.1002/bies.200800191
Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus 10.1371/journal.pone.0005660
Myths and misconceptions: The origin and evolution of Mycobacterium tuberculosis 10.1038/nrmicro2165
Mycobacterial PE, PPE and ESX clusters: Novel insights into the secretion of these most unusual protein families 10.1111/j.1365-2958.2009.06784.x
High content screening identifies decaprenyl-phosphoribose 2′ epimerase as a target for intracellular antimycobacterial inhibitors 10.1371/journal.ppat.1000645
ESX/type VII secretion systems and their role in host-pathogen interaction 10.1016/j.mib.2008.11.003
Benzothiazinones Kill Mycobacterium tuberculosis by blocking Arabinan synthesis 10.1126/science.1171583
Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis 10.1101/gr.075069.107
Functional analysis of a clonal deletion in an epidemic strain of Mycobacterium bovis reveals a role in lipid metabolism 10.1099/mic.0.2008/022269-0
Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP 10.1371/journal.ppat.0040033
BCG: Molecular history and new perspectives | Le BCG: Histoire moléculaire et nouvelles perspectives RMR-06-2008-25-00-01761-8425-101019-200806495
Genome plasticity of BCG and impact on vaccine efficacy 10.1073/pnas.0700869104
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity 10.1128/JB.00469-07
Pathogenomics: Insights into Tuberculosis and Related Mycobacterial Diseases 10.1002/352760801X.ch10
Horizontal transfer of a virulence operon to the ancestor of Mycobacterium tuberculosis 10.1093/molbev/msj120
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence 10.1128/IAI.74.1.88-98.2006
Contribution of mycobacterial genomics to the development of innovative strategies against tuberculosis | Apports de la génomique des mycobactéries a la définition de nouvelles stratégies thérapeutiques et vaccinales anti-tuberculeuses 10.1016/S1773-035X(06)80148-6
"A re-evaluation of M. prototuberculosis": Continuing the debate 10.1371/journal.ppat.0020095
Tuberculosis: From genome to vaccine 10.1586/14760584.4.4.541
Structure and mechanism of the alkyl hydroperoxidase AhpC, a key element of the Mycobacterium tuberculosis defense system against Oxidative Stress 10.1074/jbc.M503076200
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: The contribution of endogenous mycolactone toxin 10.1111/j.1462-5822.2005.00546.x
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity 10.1074/jbc.M503515200
Common evolutionary origin for the unstable virulence plasmid pMUM found in geographically diverse strains of Mycobacterium ulcerans 10.1128/JB.187.5.1668-1676.2005
Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis 10.1371/journal.ppat.0010005
Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans 10.1073/pnas.0305877101
Genotypic Analysis of Mycobacterium tuberculosis in Bangladesh and Prevalence of the Beijing Strain 10.1128/JCM.42.2.674-682.2004
ESAT-6 proteins: Protective antigens and virulence factors? 10.1016/j.tim.2004.09.007
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens 10.1086/421468
Cell Envelope Protein PPE68 Contributes to Mycobacterium tuberculosis RD1 Immunogenicity Independently of A 10-Kilodalton Culture Filtrate Protein and ESAT-6 10.1128/IAI.72.4.2170-2176.2004
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis 10.1038/nm859
Is Mycobacterium africanum subtype II (Uganda I and Uganda II) a genetically well-defined subspecies of the Mycobacterium tuberculosis complex? [3] (multiple letters) 10.1128/JCM.41.3.1345-1348.2003
Royal society of tropical medicine and hygiene meeting at Manson house, London, 18 January 2001: Pathogen genomes and human health. Mycobacterial genomics 10.1016/S0035-9203(02)90222-1
Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis 10.1128/JCM.40.7.2339-2345.2002
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti 10.1046/j.1365-2958.2002.03237.x
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant 10.1128/IAI.70.10.5568-5578.2002
A new evolutionary scenario for the Mycobacterium tuberculosis complex 10.1073/pnas.052548299
The evolution of mycobacterial pathogenicity: Clues from comparative genomics 10.1016/S0966-842X(01)02131-X
Genomics of Mycobacterium bovis 10.1054/tube.2000.0269
Tools for the population genomics of the tubercle bacilli 10.1101/gr.169200
Comparative genomics of the leprosy and tubercle bacilli 10.1016/S0923-2508(00)00117-0
Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays 10.1046/j.1365-2958.1999.01383.x
Analysis of the proteome of Mycobacterium tuberculosis in silico 10.1054/tuld.1999.0220
The high-pathogenicity island of Yersinia pseudotuberculosis can be inserted into any of the three chromosomal asn tRNA genes 10.1046/j.1365-2958.1998.01124.x
Deciphering the biology of mycobacterium tuberculosis from the complete genome sequence 10.1038/31159
Genomic fingerprinting of 80 strains from the WHO multicenter international typing study of Listeria monocytogenes via pulsed-field gel electrophoresis (PFGE) 10.1016/S0168-1605(96)01147-6
Characterization of Listeria strains isolated from soft cheese 10.1016/0168-1605(93)90220-B
Listeriosis outbreak in France in 1992. Microbial data | Epidémie de listériose en France en 1992 aspects microbiologiques 10.1016/S0399-077X(05)81214-4
Use of pulsed field gel electrophoresis to compare large DNA-restriction fragments of Listeria monocytogenes strains belonging to serogroups 1/2 and 3 10.1016/0168-1605(91)90121-5
Subtyping of Listeria monocytogenes serovar 4b by use of low-frequency-cleavage restriction endonucleases and pulsed-field gel electrophoresis 10.1016/0923-2508(91)90080-T
Impact of Mycobacterium tuberculosis RD1-locus on human primary dendritic cell immune functions 10.1038/srep17078
Revisiting the role of phospholipases C in virulence and the lifecycle of Mycobacterium tuberculosis 10.1038/srep16918
Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. 10.1016/j.tube.2010.03.008
The BCG Strain Pool: Diversity Matters. 10.1038/mt.2016.18
Genome-wide mosaicism within Mycobacterium abscessus: evolutionary and epidemiological implications. 10.1186/s12864-016-2448-1
Perspectives on mycobacterial vacuole-to-cytosol translocation: the importance of cytosolic access. 10.1111/cmi.12622
Key experimental evidence of chromosomal DNA transfer among selected tuberculosis-causing mycobacteria 10.1073/pnas.1604921113
Comparative Genomics and Evolution of Mycobacterium bovis BCG 10.1128/9781555817657.ch10
The Mycobacteria: a Postgenomic View 10.1128/9781555815530.ch3
Genomics ofMycobacterium Tuberculosis and Mycobacterium Leprae 10.1002/9781444311433.ch5
Genomics of the Mycobacterium tuberculosis complex and Mycobacterium leprae 10.1002/047001153x.g205204
ESX secretion systems: mycobacterial evolution to counter host immunity 10.1038/nrmicro.2016.131
Resistance to thiacetazone derivatives active against Mycobacterium abscessus involves mutations in the MmpL5 transcriptional repressor MAB_4384 10.1128/aac.02509-16
ESX-1 and phthiocerol dimycocerosates of Mycobacterium tuberculosis act in concert to cause phagosomal rupture and host cell apoptosis. 10.1111/cmi.12726
Colonization with Helicobacter is concomitant with modified gut microbiota and drastic failure of the immune control of Mycobacterium tuberculosis 10.1038/mi.2016.140
Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection 10.1016/j.celrep.2017.02.057
PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis 10.1371/journal.ppat.1006399
Predicting susceptibility to tuberculosis based on gene expression profiling in dendritic cells 10.1038/s41598-017-05878-w
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101
Evolution of virulence in the Mycobacterium tuberculosis complex 10.1016/j.mib.2017.11.021
The Macrophage: A Disputed Fortress in the Battle against Mycobacterium tuberculosis 10.3389/fmicb.2017.02284
Mutations in ppe38 block PE_PGRS secretion and increase virulence of Mycobacterium tuberculosis 10.1038/s41564-017-0090-6
Discovery of the type VII ESX-1 secretion needle? 10.1111/mmi.13579
Identification of genes required forMycobacterium abscessusgrowth in vivo with a prominent role of the ESX-4 locus 10.1073/pnas.1713195115
Mycobacterial ESX-1 secretion system mediates host cell lysis through bacterium contact-dependent gross membrane disruptions 10.1073/pnas.1620133114
Horizontal acquisition of a hypoxia-responsive molybdenum cofactor biosynthesis pathway contributed to Mycobacterium tuberculosis pathoadaptation 10.1371/journal.ppat.1006752
The Biology and Epidemiology of Mycobacterium canettii 10.1007/978-3-319-64371-7_2
Targeting Type VII/ESX Secretion Systems for Development of Novel Antimycobacterial Drugs 10.2174/1381612819666131118170717
Taxonomic Diversity of Pseudomonads Revealed by Computer-interpretation of Ribotyping Data 10.1016/s0723-2020(96)80026-9
Comparative genomics of the mycobacteria 10.1016/s1438-4221(00)80083-1
Single Cell Measurements of Vacuolar Rupture Caused by Intracellular Pathogens 10.3791/50116
Type VII Secretion Systems in Gram-Positive Bacteria 10.1007/82_2015_5015
Genomic characterization of Mycobacterium tuberculosis lineage 7 and a proposed name: ‘Aethiops vetus’ 10.1099/mgen.0.000063
Leprosy in red squirrels 10.1126/science.aal0145
CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection 10.1371/journal.ppat.1005770
pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence 10.1038/nmicrobiol.2015.19
A unique PE_PGRS protein inhibiting host cell cytosolic defenses and sustaining full virulence ofMycobacterium marinumin multiple hosts 10.1111/cmi.12606
The PE and PPE Protein Families of Mycobacterium tuberculosis 10.1002/9783527611614.ch7
Influence of ESAT-6 Secretion System 1 (RD1) of Mycobacterium tuberculosis on the Interaction between Mycobacteria and the Host Immune System 10.4049/jimmunol.174.6.3570
Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors 10.1016/j.celrep.2018.03.125
ESAT-6–dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo 10.1172/jci84978
Cutting-edge science and the future of tuberculosis control 10.2471/blt.06.035386
ESAT-6 and the Mycobacterial ESX Secretion Systems 10.1128/9781555815783.ch13
RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection 10.1371/journal.ppat.1007139
Unexpected genomic and phenotypic diversity of Mycobacterium africanum Lineage 5 affects drug resistance, protein secretion and immunogenicity 10.1093/gbe/evy145
New substrates and interactors of the mycobacterial Serine/Threonine protein kinase PknG identified by a tailored interactomic approach 10.1016/j.jprot.2018.09.013
Update on the virulence factors of the obligate pathogen Mycobacterium tuberculosis and related tuberculosis-causing mycobacteria 10.1016/j.meegid.2018.12.013
Shared Pathogenomic Patterns Characterize a New Phylotype, Revealing Transition toward Host-Adaptation Long before Speciation of Mycobacterium tuberculosis 10.1093/gbe/evz162
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis. 10.1021/acsnano.8b07902
Mycobacterial virulence: impact on immunogenicity and vaccine research 10.12688/f1000research.20572.1
TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineages 10.1038/s41467-020-14508-5
Discovery of a novel dehydratase of the fatty acid synthase type II critical for ketomycolic acid biosynthesis and virulence of Mycobacterium tuberculosis 10.1038/s41598-020-58967-8
ESX/Type VII Secretion Systems—An Important Way Out for Mycobacterial Proteins 10.1128/microbiolspec.psib-0029-2019
ESX-4, un système de sécrétion mycobactérien ancestral, essentiel pour la croissance de Mycobacterium abscessus dans les phagocytes environnementaux et humains 10.1051/medsci/2018196
Mycobacterium abscessus virulence traits unraveled by transcriptomic profiling in amoeba and macrophages 10.1371/journal.ppat.1008069
A systematic approach to simultaneously evaluate safety, immunogenicity, and efficacy of novel tuberculosis vaccination strategies 10.1126/sciadv.aaz1767
Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro–American genetic background confers optimal vaccine potential 10.1016/j.ebiom.2020.102761
Mucosal delivery of ESX-1–expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes 10.1073/pnas.2003235117
Le BCG : histoire moléculaire et nouvelles perspectives 10.1016/s0761-8425(08)56032-3
Breaching the phagosome, the case of the tuberculosis agent 10.1111/cmi.13344
Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts 10.1099/mgen.0.000505
The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection 10.7554/elife.55692
IL-1R1-Dependent Signals Improve Control of Cytosolic Virulent Mycobacteria In Vivo 10.1128/mSphere.00153-21
ESX-1-Independent Horizontal Gene Transfer by Mycobacterium tuberculosis Complex Strains 10.1128/mBio.00965-21
Evolution of Mycobacterium tuberculosis : New Insights into Pathogenicity and Drug Resistance 10.1128/microbiolspec.tbtb2-0020-2016
Phthiocerol Dimycocerosates From Mycobacterium tuberculosis Increase the Membrane Activity of Bacterial Effectors and Host Receptors 10.3389/fcimb.2020.00420
Parallel in vivo experimental evolution reveals that increased stress resistance was key for the emergence of persistent tuberculosis bacilli 10.1038/s41564-021-00938-4
Katarina Mikusova
Mikusova Katarina
ORCID: 0000-0002-0100-4877
Time-adjusted Analysis Shows Weak Associations Between BCG Vaccination Policy and COVID-19 Disease Progression 10.1101/2020.05.01.20087809
Synthesis, docking study and biological evaluation of ᴅ-fructofuranosyl and ᴅ-tagatofuranosyl sulfones as potential inhibitors of the mycobacterial galactan synthesis targeting the galactofuranosyltransferase GlfT2 10.3762/bjoc.16.152
Synthesis of the Arabinose Donor .beta.-D-Arabinofuranosyl-1-monophosphoryldecaprenol, Development of a Basic Arabinosyl-Transferase Assay, and Identification of Ethambutol as an Arabinosyl Transferase Inhibitor 10.1021/ja00153a002
Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors 10.1021/acs.jmedchem.0c00007
Development of Macozinone for TB treatment: An Update 10.3390/app10072269
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents 10.1016/j.ejmech.2020.112773
Biosynthesis of Galactan in Mycobacterium tuberculosis as a Viable TB Drug Target? 10.3390/antibiotics9010020
New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053 10.1021/acsinfecdis.9b00388
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2′-Oxidase 10.1021/acs.jmedchem.9b00912
Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents 10.1016/j.chembiol.2019.02.013
New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action 10.1016/j.ejmech.2018.04.017
Copper-related toxicity in replicating and dormantMycobacterium tuberculosiscaused by 1-hydroxy-5-R-pyridine-2(1H)-thiones 10.1039/c8mt00067k
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 10.1038/s41598-018-21614-4
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535
Learning from the past for TB drug discovery in the future 10.1016/j.drudis.2016.09.025
N-Acetylglucosamine-1-Phosphate Transferase, WecA, as a Validated Drug Target in Mycobacterium tuberculosis 10.1128/aac.01310-17
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors 10.1021/acsinfecdis.7b00006
Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043 10.1021/acsmedchemlett.5b00424
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis 10.1021/acs.jmedchem.5b00608
Assembling of theMycobacterium tuberculosisCell Wall Core 10.1074/jbc.m116.739227
Structural basis for selective recognition of acyl chains by the membrane-associated acyltransferase PatA 10.1038/ncomms10906
Lead selection and characterization of antitubercular compounds using the Nested Chemical Library 10.1016/j.tube.2015.02.028
The Complex Mechanism of Antimycobacterial Action of 5-Fluorouracil 10.1016/j.chembiol.2014.11.006
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG 10.1016/j.chembiol.2015.05.016
The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis 10.1128/aac.00778-15
GtrA Protein Rv3789 Is Required for Arabinosylation of Arabinogalactan in Mycobacterium tuberculosis 10.1128/jb.00628-15
DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization 10.1021/acschembio.5b00237
Purification and characterization of the acyltransferase involved in biosynthesis of the major mycobacterial cell envelope glycolipid – Monoacylated phosphatidylinositol dimannoside 10.1016/j.pep.2014.04.014
DprE1 - from the Discovery to the Promising Tuberculosis Drug Target 10.2174/138161282027140630122724
The Phosphatidyl-myo-Inositol Mannosyltransferase PimA Is Essential for Mycobacterium tuberculosis Growth In Vitro and In Vivo 10.1128/jb.01346-13
AnethA-ethR-Deficient Mycobacterium bovis BCG Mutant Displays Increased Adherence to Mammalian Cells and Greater PersistenceIn Vivo, Which Correlate with Altered Mycolic Acid Composition 10.1128/iai.01332-13
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis 10.1073/pnas.1309171110
Novel synthetic (1 → 6)-α-d-mannodisaccharide substrates support processive mannosylation catalysed by the mycobacterial cell envelope enzyme fraction 10.1039/c3ra43575j
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2′-Oxidase DprE1 10.1021/ja211042r
A Small Multidrug Resistance-like Transporter Involved in the Arabinosylation of Arabinogalactan and Lipoarabinomannan in Mycobacteria 10.1074/jbc.m112.400986
Protein Separation and Enzyme Purification by Preparative Capillary Isotachophoresis 10.1007/s10337-012-2348-8
Synthesis of 1,2,3-Triazolo-Linked Octyl (1→6)-α-d-Oligomannosides and Their Evaluation in Mycobacterial Mannosyltransferase Assay 10.1021/bc100421g
Investigation of ABC transporter from mycobacterial arabinogalactan biosynthetic cluster 10.4149/gpb_2011_03_239
Biosynthetic Origin of the Galactosamine Substituent of Arabinogalactan inMycobacterium tuberculosis 10.1074/jbc.m110.188110
Synthesis of alkyl and cycloalkyl α-d-mannopyranosides and derivatives thereof and their evaluation in the mycobacterial mannosyltransferase assay 10.1016/j.carres.2010.03.011
Synthetic UDP-Furanoses as Potent Inhibitors of Mycobacterial Galactan Biogenesis 10.1016/j.chembiol.2010.10.014
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance 10.1111/j.1365-2958.2010.07277.x
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 10.1126/science.1171583
Stereoselective syntheses of heptaprenylphosphoryl β-d-arabino-and β-d-ribo-furanoses 10.1016/j.tetlet.2009.02.188
Galactosyl Transferases in Mycobacterial Cell Wall Synthesis 10.1128/jb.01326-07
Identification of promoters recognized by RNA polymerase containing Mycobacterium tuberculosis stress-response sigma factor σF 10.1007/s00203-006-0185-6
Molecular Recognition and Interfacial Catalysis by the Essential Phosphatidylinositol Mannosyltransferase PimA from Mycobacteria 10.1074/jbc.m702087200
Identification of a Novel Galactosyl Transferase Involved in Biosynthesis of the Mycobacterial Cell Wall 10.1128/jb.00489-06
Decaprenylphosphoryl Arabinofuranose, the Donor of the d-Arabinofuranosyl Residues of Mycobacterial Arabinan, Is Formed via a Two-Step Epimerization of Decaprenylphosphoryl Ribose 10.1128/jb.187.23.8020-8025.2005
Polymerization of Mycobacterial Arabinogalactan and Ligation to Peptidoglycan 10.1074/jbc.m302216200
Identification of the Required Acyltransferase Step in the Biosynthesis of the Phosphatidylinositol Mannosides ofMycobacteriumSpecies 10.1074/jbc.m303639200
Definition of the First Mannosylation Step in Phosphatidylinositol Mannoside Synthesis 10.1074/jbc.m204060200
Biosynthesis of the Galactan Component of the Mycobacterial Cell Wall 10.1074/jbc.m006875200
Interaction of Human Mannose‐Binding Protein withMycobacterium avium 10.1086/520354
Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds 10.1039/D0MD00390E
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 10.1021/acsinfecdis.0c00622
An ABC transporter Wzm-Wzt catalyzes translocation of lipid-linked galactan across the plasma membrane in mycobacteria. 10.1073/pnas.2023663118
Maria Rosalia PASCA
PASCA Maria Rosalia
ORCID: 0000-0002-8906-4937
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG 10.1016/j.chembiol.2015.05.016
Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth 10.1016/j.ejmech.2015.06.035
2-carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1 10.1021/cb5007163
Pyridine-3,4-dicarboximide as starting material for the total synthesis of the natural product eupolauramine and its isomer iso-eupolauramine endowed with anti-tubercular activities 10.1016/j.tet.2015.01.034
Differential roles of rnd efflux pumps in antimicrobial drug resistance of sessile and planktonic burkholderia cenocepacia cells 10.1128/AAC.03800-14
Trends in discovery of new drugs for tuberculosis therapy 10.1038/ja.2014.109
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis 10.1021/cb500149m
4-Aminoquinolone piperidine amides: Noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity 10.1021/jm5005978
Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis 10.1016/j.ejmech.2013.10.069
DprE1, a new taxonomic marker in mycobacteria 10.1111/1574-6968.12246
The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis 10.1007/s00253-013-5218-x
Synthesis and evaluation of α-ketotriazoles and α,β- diketotriazoles as inhibitors of Mycobacterium tuberculosis 10.1016/j.ejmech.2013.06.042
A census of RND superfamily proteins in the Burkholderia genus 10.2217/fmb.13.50
Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection 10.1371/journal.pone.0056980
Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems 10.1371/journal.pone.0055112
Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis 10.1016/j.ejmech.2013.09.041
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis 10.1126/scitranslmed.3004395
Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents 10.1016/j.ejmech.2012.03.029
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates 10.1089/mdr.2011.0019
Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-d-ribofuranose 2′-oxidase DprE1 10.1021/ja211042r
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 10.1128/AAC.05270-11
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675
Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents 10.1016/j.ejmech.2011.09.013
Deciphering the role of rnd efflux transporters in burkholderia cenocepacia 10.1371/journal.pone.0018902
Mycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: Biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesis 10.1371/journal.pone.0015494
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance 10.1111/j.1365-2958.2010.07277.x
Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target 10.2174/092986710791959693
Exploring the HME and HAE1 efflux systems in the genus Burkholderia 10.1186/1471-2148-10-164
Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones 10.1128/AAC.01676-09
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance 10.1186/1471-2180-9-200
Control of MRSA infection and colonisation in an intensive care unit by GeneOhm MRSA assay and culture methods 10.1186/1471-2334-9-137
Mycobacterium tuberculosis: Drug resistance and future perspectives 10.2217/fmb.09.20
Benzothiazinones Kill Mycobacterium tuberculosis by blocking Arabinan synthesis 10.1126/science.1171583
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system 10.1016/j.tube.2008.08.003
Genomic analysis of zinc homeostasis in Mycobacterium tuberculosis 10.1111/j.1574-6968.2008.01320.x
Global analysis of the Mycobacterium tuberculosis Zur (FurB) regulon 10.1128/JB.01190-06
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 10.1128/AAC.00656-06
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 10.1186/1471-2180-6-66
mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis 10.1128/AAC.49.11.4775-4777.2005
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain 10.1016/j.resmic.2004.08.011
Characterization and heterologous expression of the oxalyl coenzyme a decarboxylase gene from Bifidobacterium lactis 10.1128/AEM.70.9.5066-5073.2004
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis 10.1128/AAC.48.8.3175-3178.2004
The Redox State Regulates the Conformation of Rv2466c to Activate the Antitubercular Prodrug TP053 10.1074/jbc.M115.677039
New Potential Drugs Targets For Burkholderia: Insights From In Silico Analyses 10.1016/j.jbiotec.2010.09.650
Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity 10.1002/cmdc.201600085
New prodrugs against tuberculosis 10.1016/j.drudis.2016.09.006
Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis. 10.1016/j.ejmech.2016.07.028
Evaluation of the inhibitory activity of (aza)isoindolinone-type compounds: toward in vitro InhA action, Mycobacterium tuberculosis growth and mycolic acid biosynthesis. 10.1111/cbdd.12804
Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity 10.3390/molecules22091457
Erratum: Antituberculars which target decaprenylphosphoryl-β-D- ribofuranose 2'-oxidase DprE1: State of art (Applied Microbiology and Biotechnology (2012) 94 (907-916) DOI: 10.1007/s00253-012-4013-4) 10.1007/s00253-012-4217-7
Antituberculars which target decaprenylphosphoryl-β-Dribofuranose 2′-oxidase DprE1: State of art 10.1007/s00253-012-4013-4
Shifts of Faecal Microbiota during Sporadic Colorectal Carcinogenesis 10.1038/s41598-018-28671-9
Iron acquisition pathways as targets for antitubercular drugs 10.2174/0929867323666160607223747
New and old hot drug targets in tuberculosis 10.2174/1389557516666160831164925
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors 10.1021/acsinfecdis.7b00006
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 10.1038/s41598-018-21614-4
Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3 10.3390/app10020623
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 10.1021/acsmedchemlett.0c00173
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 10.3389/fmicb.2020.559469
Nitric oxide-releasing compounds for the treatment of lung infections 10.1016/j.drudis.2020.10.027
Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer 10.3390/ijms22031312
The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism 10.3390/ijms22168533